Datasets:

databio
/

term-knowledge

Modalities:

Text

Formats:

Size:

Libraries:

Dataset card Data Studio Files Files and versions Community

term-knowledge

File size: 166,636 Bytes

63d9254

BTO_0001948	JURKAT E-6.1 cell	Human, blood, leukemia, T cell line, clone E6.1.
EFO_0002796	Jurkat	A cell line derived from human T cell acute lymphoblastic leukemia.
EFO_0022656	J.CaM1.6	Human T lymphoblast cell line
CLO_0010521	GM08388	 ATAXIA-TELANGIECTASIA MUTATED GENE; ATM ATAXIA-TELANGIECTASIA; AT
CLO_0010523	GM08390	 ATAXIA-TELANGIECTASIA MUTATED GENE; ATM ATAXIA-TELANGIECTASIA; AT
CLO_0010526	GM08398	 APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0010557	GM08436	 ATAXIA-TELANGIECTASIA; AT ATAXIA-TELANGIECTASIA MUTATED GENE; ATM
CLO_0011234	GM08931	 ATAXIA-TELANGIECTASIA; AT
CLO_0011235	GM08930	 ATAXIA-TELANGIECTASIA; AT
CLO_0011237	GM08928	 ATAXIA-TELANGIECTASIA; AT
CLO_0011391	GM09585	 ATAXIA-TELANGIECTASIA MUTATED GENE; ATM ATAXIA-TELANGIECTASIA; AT
CLO_0011394	GM09583	 ATAXIA-TELANGIECTASIA; AT
CLO_0011436	GM09581	 ATAXIA-TELANGIECTASIA; AT
CLO_0011438	GM09579	 ATAXIA-TELANGIECTASIA; AT
CLO_0012496	ND03432	 PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES PARKINSON'S DISEASE
CLO_0013077	GM17289	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013080	GM17288	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013082	GM17287	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013086	GM17286	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013090	GM17285	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013092	GM17284	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013094	GM17282	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013095	GM17283	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013096	GM17280	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6; CYP2D6 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CLO_0013097	GM17281	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200
CLO_0013124	GM17296	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013127	GM17295	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013135	GM17291	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013136	GM17292	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013137	GM17293	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013138	GM17294	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013140	GM17290	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013163	GM17265	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013168	GM17264	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013169	GM17263	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013173	GM17262	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013176	GM17269	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013177	GM17268	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013179	GM17267	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013181	GM17266	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013182	GM17260	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013183	GM17261	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013193	GM17274	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6; CYP2D6 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013197	GM17273	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013199	GM17276	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013202	GM17275	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013204	GM17278	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013208	GM17277	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013210	GM17279	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013212	GM17270	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013213	GM17271	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013214	GM17272	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013751	GM17180	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013752	GM17184	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013753	GM17183	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013754	GM17182	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013755	GM17181	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013775	GM17187	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013777	GM17188	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013781	GM17185	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013784	GM17186	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013790	GM17189	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013793	GM17191	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013794	GM17190	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013795	GM17193	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013796	GM17192	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013797	GM17195	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013798	GM17194	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013816	GM17196	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013818	GM17197	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013823	GM17198	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013826	GM17199	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013833	GM17206	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013834	GM17205	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0013835	GM17204	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0013836	GM17203	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013837	GM17202	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013839	GM17201	 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0013840	GM17200	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013875	GM17209	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0013881	GM17207	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013884	GM17208	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0013885	GM17215	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013886	GM17214	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013887	GM17217	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0013888	GM17216	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0013890	GM17211	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013891	GM17210	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6; CYP2D6 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013893	GM17213	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0013895	GM17212	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0013921	GM17218	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013924	GM17219	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013935	GM17140	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0013936	GM17144	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013937	GM17143	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013938	GM17142	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013939	GM17141	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013940	GM17148	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0013941	GM17147	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0013942	GM17146	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0013943	GM17145	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0013947	GM17149	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013956	GM17150	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013960	GM17155	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013961	GM17154	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013962	GM17157	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013963	GM17156	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013964	GM17159	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013965	GM17158	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 SNP500 PANEL
CLO_0013982	GM17161	 SNP500 PANEL HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013983	GM17162	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013984	GM17160	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013987	GM17168	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013989	GM17167	 SNP500 PANEL HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013990	GM17166	 SNP500 PANEL HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013993	GM17165	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013994	GM17164	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013996	GM17163	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014022	GM17170	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014024	GM17171	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014025	GM17172	 SNP500 PANEL HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014026	GM17173	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014028	GM17179	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014029	GM17178	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014033	GM17175	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014034	GM17174	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014037	GM17177	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014039	GM17176	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014327	GM17239	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014330	GM17237	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014332	GM17238	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014334	GM17235	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014336	GM17236	 CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6; CYP2D6 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014338	GM17233	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014340	GM17234	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014341	GM17231	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014344	GM17232	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014347	GM17230	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014356	GM17226	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014358	GM17227	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6; CYP2D6 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014359	GM17228	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014362	GM17229	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014366	GM17222	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014367	GM17223	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014369	GM17224	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014371	GM17225	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014375	GM17220	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014377	GM17221	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014388	GM17259	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014389	GM17253	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014390	GM17254	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014391	GM17251	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200
CLO_0014392	GM17252	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014393	GM17257	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014394	GM17258	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014395	GM17255	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014396	GM17256	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014397	GM17250	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014404	ND02579	 PARKINSON'S DISEASE PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES
CLO_0014408	GM17248	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014409	GM17249	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014410	GM17240	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014411	GM17241	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014412	GM17242	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014413	GM17243	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014414	GM17244	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014415	GM17245	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014416	GM17246	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014417	GM17247	 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014788	GM02783	 ATAXIA-TELANGIECTASIA; AT
CLO_0014806	GM02767	 ANEUPLOID CHROMOSOME NUMBER - TRISOMY TRISOMY 21
CLO_0014887	GM17109	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16
CLO_0014889	GM17108	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0014896	GM17102	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0014898	GM17103	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0014900	GM17104	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0014901	GM17105	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0014902	GM17106	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0014903	GM17107	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0014942	GM17119	 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014943	GM17113	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0014945	GM17114	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8
CLO_0014947	GM17111	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8
CLO_0014948	GM17112	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0014950	GM17117	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014951	GM17118	 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014952	GM17115	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1
CLO_0014953	GM17116	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0014964	GM17110	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8
CLO_0015081	GM17132	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0015082	GM17133	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0015085	GM17130	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1
CLO_0015087	GM17131	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1
CLO_0015088	GM17136	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16
CLO_0015090	GM17137	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0015093	GM17134	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0015094	GM17135	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0015097	GM17138	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0015098	GM17139	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0015112	GM17120	 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0015115	GM17121	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0015117	GM17122	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0015119	GM17123	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0015121	GM17124	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0015123	GM17125	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0015124	GM17126	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0015126	GM17127	 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0015128	GM17128	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0015130	GM17129	 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1
CLO_0015209	ND02852	 PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES PARKINSON'S DISEASE
CLO_0016362	ND01737	 PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES PARKINSON'S DISEASE
CLO_0016449	GM17852	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016450	GM17850	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016453	GM17845	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016454	GM17844	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016455	GM17847	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016456	GM17846	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016457	GM17842	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016458	GM17843	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016489	GM17798	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016490	GM17799	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016491	GM17800	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016492	GM17801	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016493	GM17796	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016494	GM17797	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016495	GM17802	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016496	GM17803	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016497	GM17804	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016498	GM17805	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016499	GM17811	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016500	GM17812	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016501	GM17809	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016502	GM17810	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016503	GM17807	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016504	GM17808	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016505	GM17806	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016506	GM17815	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016507	GM17813	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016508	GM17814	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016509	GM17816	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016510	GM17817	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016511	GM17818	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016515	GM17823	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016516	GM17824	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016517	GM17825	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016518	GM17826	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016519	GM17833	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016520	GM17835	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016521	GM17828	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016522	GM17831	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016523	GM17839	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016524	GM17840	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016525	GM17837	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016526	GM17838	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016527	GM17841	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016528	GM17827	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016554	GM17756	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016555	GM17755	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24
CLO_0016558	GM17754	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24
CLO_0016560	GM17753	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24
CLO_0016561	GM17752	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016564	GM17749	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016565	GM17747	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016566	GM17746	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016567	GM17745	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016568	GM17744	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016593	GM17767	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016594	GM17766	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016597	GM17768	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016600	GM17762	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016601	GM17761	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24
CLO_0016602	GM17765	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016604	GM17764	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016606	GM17757	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8
CLO_0016607	GM17759	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8
CLO_0016608	GM17758	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016635	GM17779	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016636	GM17776	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016638	GM17775	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016641	GM17774	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016642	GM17782	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016643	GM17780	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016645	GM17773	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016646	GM17771	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016647	GM17770	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016648	GM17769	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016672	GM17792	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016675	GM17791	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016676	GM17794	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016678	GM17793	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016682	GM17795	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016684	GM17783	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016685	GM17787	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016686	GM17785	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016687	GM17790	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016688	GM17789	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016951	GM07348	 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 SNP500 PANEL HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 8 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 CEPH/UTAH PEDIGREE 1345
CLO_0016995	GM17733	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16
CLO_0017020	GM17741	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24
CLO_0017021	GM17740	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8
CLO_0017022	GM17739	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24
CLO_0017023	GM17738	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0017024	GM17743	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0017025	GM17742	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0017043	GM17736	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16
CLO_0017044	GM17737	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8
CLO_0017045	GM17734	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16
CLO_0017046	GM17735	 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16
CLO_0018566	ND06449	 LATE ONSET PARKINSON'S DNA PANEL, AFFECTED INDIVIDUALS PARKINSON'S DISEASE
CLO_0019004	GM12264	 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1375 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CLO_0020019	GM11840	 CEPH/UTAH PEDIGREE 1349 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CLO_0021459	AG10941	 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0021565	AG11498	 LAMIN A/C; LMNA HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS
CLO_0021597	AG11364	 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0021875	AG10049	 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0021913	AG09699	 GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA)
CLO_0021943	AG09877	 GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA)
CLO_0022101	AG13150	 GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA)
CLO_0022107	AG13145	 GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA)
CLO_0022132	AG13066	 GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA)
CLO_0022320	AG14446	 GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA)
CLO_0022362	AG11696	 GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA)
CLO_0022371	AG11726	 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0022604	AG11513	 LAMIN A/C; LMNA HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS
CLO_0023783	GM10845	 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 8 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 CEPH/UTAH PEDIGREE 1424
CLO_0023784	GM10842	 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 8 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 CEPH/UTAH PEDIGREE 1423
CLO_0023785	GM10843	 CEPH/UTAH PEDIGREE 1423 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1
CLO_0023794	GM10832	 SNP500 PANEL CEPH/UTAH PEDIGREE 1413
CLO_0023795	GM10833	 CEPH/UTAH PEDIGREE 1413 SNP500 PANEL
CLO_0025850	GM00144	 TRANSLOCATED CHROMOSOME TRISOMY 21
CLO_0026349	ND00259	 POPULATION/CONVENIENCE CONTROL
CLO_0026399	ND00268	 POPULATION/CONVENIENCE CONTROL
CLO_0026786	GM15386	 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0026789	GM15385	 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027048	ND00397	 ISCHEMIC STROKE NDPT081 ISCHEMIC STROKE DNA PANEL
CLO_0027182	GM15324	 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027328	GM15268	 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027391	GM15245	 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027447	GM15242	 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027467	GM15236	 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027473	GM15227	 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027483	GM15223	 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027484	GM15224	 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027486	GM15226	 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027487	GM15221	 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027491	GM15216	 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9
CLO_0027492	GM15215	 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027493	GM15213	 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0028103	GM15590	 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0028397	ND01173	 PARKINSON'S DISEASE PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES
CLO_0029036	ND06229	 POPULATION/CONVENIENCE CONTROL
CLO_0029732	ND00051	 POPULATION/CONVENIENCE CONTROL
CLO_0029916	GM15144	 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0030105	ND00022	 POPULATION/CONVENIENCE CONTROL
CLO_0030305	GM15029	 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9
CLO_0030309	GM15038	 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0030311	GM15036	 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0030324	GM15061	 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0030328	GM15056	 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0030337	GM15072	 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0030688	ND00151	 POPULATION/CONVENIENCE CONTROL
CLO_0031189	GM14381	 APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS
CLO_0031198	GM14382	 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031201	GM14405	 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031225	GM14414	 APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS
CLO_0031226	GM14409	 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031227	GM14408	 MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031228	GM14406	 NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS
CLO_0031232	AG08904	 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0031234	GM14439	 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031236	GM14433	 NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS
CLO_0031238	GM14432	 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031239	GM14417	 MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031253	GM14453	 APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS
CLO_0031254	GM14454	 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031256	GM14455	 MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031257	GM14440	 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031260	GM14447	 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031261	GM14448	 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031263	GM14452	 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031272	GM14475	 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031274	GM14476	 MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031275	GM14465	 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031276	GM14467	 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031278	GM14464	 NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS
CLO_0031280	GM14474	 NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS
CLO_0031281	GM14468	 MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031504	GM14501	 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031509	GM14503	 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031510	GM14502	 NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS
CLO_0031516	GM14504	 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031517	GM14507	 MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031519	GM14506	 MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031529	GM14478	 NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS
CLO_0031531	GM14477	 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031533	GM14481	 MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031534	GM14480	 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031535	GM14479	 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031580	GM14568	 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031581	GM14569	 APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS
CLO_0031585	GM14581	 APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS
CLO_0031600	GM14535	 APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS
CLO_0031601	GM14536	 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031606	GM14532	 MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031607	GM14533	 NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS
CLO_0031609	GM14509	 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031610	GM14508	 MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031611	GM14520	 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031612	GM14521	 NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS
CLO_0031665	GM14583	 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031666	GM14582	 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031668	GM14584	 NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS
CLO_0031953	GM14679	 NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0032601	ND04158	 PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES PARKINSON'S DISEASE
CLO_0032713	GM13649	 COLORECTAL CANCER, FAMILIAL
CLO_0033199	GM13883	 ATAXIA-TELANGIECTASIA; AT
CLO_0033570	AG08048	 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0033577	AG08046	 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0033628	GM13811	 ATAXIA-TELANGIECTASIA; AT
CLO_0033747	ND04424	 PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES PARKINSON'S DISEASE
CLO_0033909	GM13995	 ATAXIA-TELANGIECTASIA; AT
CLO_0034375	GM14153	 ATAXIA-TELANGIECTASIA; AT
CLO_0034780	AG04147	 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0034796	AG04351	 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0034915	AG04655	 GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA)
CLO_0035232	AG05416	 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0035254	AG06237	 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0035579	AG07307	 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0035608	AG07139	 GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA)
CLO_0036460	GM06944	 TRANSLOCATED CHROMOSOME
CLO_0036870	GM07029	 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1340 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
EFO_0001092	BT20	A cell line derived from epithelial cells of human breast carcinoma.
EFO_0001149	GM12750	A lymphoblastoid cell line derived from CEPH/UTAH PEDIGREE 1444.
EFO_0001168	HCC1007	A cell line derived from epithelial cells of human breast carcinoma.
EFO_0001185	HeLa	A cell line derived from epithelial cells of human cervical carcinoma.
EFO_0022666	HeLa M	HeLa derived cell line
EFO_0022709	BEL-7402	Human cervical adenocarcinoma cell line
EFO_0022716	WRL-68	Hela cells containing human papilloma viral (HPV) DNA sequences
EFO_0001187	HepG2	human hepatocellular carcinoma (HCC) cells (p53-wt).
EFO_0009375	184-hTERT	Telomerase-immortalized human breast epithelial cell line.
EFO_0001195	IMR-32	A cell line derived from vertebrate neuroblastoma.
EFO_0001196	IMR-90	Human Fetal Lung Fibroblast cell line
EFO_0001199	LY2	A cell line derived from epithelial cells of a breast carcinoma.
EFO_0001203	MCF-7	Human breast adenocarcinoma, established from the pleural effusion of a 69-year-old caucasian woman with metastatic mammary carcinoma (after radio- and hormone therapy) in 1970; cells were described of being positive for cytoplasmic estrogen receptors and having the capability to form domes.
EFO_0001236	SKBR3	A cell line derived from epithelial cells of human breast carcinoma.
EFO_0001239	SUM1315MO2	Human SUM1315- metastatic/invasive  breast ductal carcinoma cell line
EFO_0001247	T-47D cell	Epithelial cells derived from human breast tumour
EFO_0001253	THP-1	A human cell line derived from peripheral blood monocytes. The patient was a 1-year-old male infant with acute monocytic leukemia.
EFO_0002059	HT-1080 cell	Human with IEF of AST, LDH, NP established from the biopsy from a fibrosarcoma of a 35-year-old Caucasian man in 1972
EFO_0002067	K562	Human chronic myeloid leukemia in blast crisis established from the pleural effusion of a 53-year-old woman with chronic myeloid leukemia (CML) in blast crisis in 1970; cells can be used as highly sensitive targets in in-vitro natural killer assays; cells produce hemoglobin; cells carry the Philadelphia chromosome with a b3-a2 fusion gene.
EFO_0002069	KELLY	A cell line derived from human neuroblastoma.
EFO_0002071	LNCAP	Human prostate carcinoma, established from the left supraclavicular lymph node metastasis from a 50-year-old man with prostate carcinoma in 1977; cells were described to be androgen-sensitive.
EFO_0002074	PC-3	Human prostate carcinoma cell line; established from the bone marrow metastasis isolated post-mortem from a 62-year-old Caucasian man with grade IV prostate cancer, poorly differentiated adenocarcinoma, after androgen suppression therapy; described to form tumors in nude mice, to grow in soft agar, and to be unresponsive to androgen treatment.
EFO_0002075	PEL-5	PEL-5 is a human primary effusion lymphoma cell line
EFO_0002077	Ramos	Ramos cell line is an EBV-negative, HLA class 1 positive B-lymphoblastoid cell line derived from a Burkitt lymphoma
EFO_0002085	T98G	Human, Caucasian, glioblastoma cell line.
EFO_0002086	TIVE	TIVE is a human cell line.
EFO_0002095	22Rv1	A cell line derived from human prostate carcinoma.
EFO_0002100	A101D	A cell line derived from human skin melanoma.
EFO_0002113	BDCM	A cell line derived from human acute myeloid leukemia.
EFO_0002117	BM1604	A cell line derived from human prostate carcinoma.
EFO_0002178	FaDu	Cell line derived from squamous cell carcinoma of the hypopharynx.
EFO_0002179	G401	A human cell line derived from a pediatric patient initially classified as Wilm's tumor, reclassified as deriving from a rhabdoid tumor of the kidney.
EFO_0002180	G402	A human cell line derived from some renal leiomyeloblastoma
EFO_0002182	GCT	A Giant Cell Tumor (GCT) cell line derived from a human fibrous histiocytoma  lung metastasis
EFO_0002183	GDM1	A cell line derived from a human patient with Philadelphia chromosome negative myeloproliferative disorder, after transformation to acute myelomonoblastic leukemia.http://www.ncbi.nlm.nih.gov/pubmed/6296552
EFO_0002184	H4	A cell line of epithelial morphology derived from adult human brain.
EFO_0002205	Hep3B	human hepatocellular carcinoma (HCC) cells (p53-null).
EFO_0002215	Jiyoye	"A Jiyoye is a cell line.
A Jiyoye is bearer of a Burkitt's lymphoma."
EFO_0002225	L428	Human Hodgkin lymphoma L-428 cells
EFO_0002289	NCI-H295R	Human NCI-H295R Adrenocortical Carcinoma
EFO_0002300	NCI-H69	Human Caucasian lung small cell carcinoma cell line.
EFO_0002314	RCHACV	RCH-ACV cell line is a human B cell precursor leukemia cell line established from a bone marrow sample of a child with acute lymphoblastic leukemia.
EFO_0002323	RWPE1	Epithelial cells derived from the peripheral zone of a histologically normal adult human prostate were transfected with a single copy of the human papilloma virus 18 (HPV-18) to establish the RWPE-1 (ATCC CRL-11609) cell line. [PMID:9214605].
EFO_0002337	SKNEP1	SKNEP1 is a human kidney cell line derived from a patient with Nephroblastoma.
EFO_0002352	SR	"Human anaplastic large T cell lymphoma cell line established from the pleural effusion an 11-year-old boy with CD30+ (Ki-1) large T cell lymphoma in 1983 (also described as ""SR""); described to express the NPM1-ALK (NPM-ALK) fusion gene (DSMZ catalog number ACC 369)"
EFO_0002360	SW1353	Human chondrosarcoma cell line
EFO_0002392	Y79	human Y79 retinoblastoma cells
EFO_0002709	BxPC-3	Human pancreatic adenocarcinoma cell line, established from a 61 year old human female.
EFO_0002711	F13	Normal pancreatic cell line
EFO_0002712	KIF5	A normal pancreas cell line.
EFO_0002713	Panc1	PANC-1 is a human pancreatic cancer cell line isolated from a pancreatic carcinoma of ductal cell origin in a 56-year-old male.
EFO_0002777	Normal Human Astrocytes	NHA is a cell line derived from normal (healthy) human astrocyte cells.
EFO_0002778	BG02ES	BG02ES is a cell line dervied from human embryonic stem cells.
EFO_0002782	glioblastoma H54	Glioblastoma H54 is a cell line derived from
EFO_0002783	GM06990	GM06990 is a cell line derived from some lymphoblastoid cells from a CEPH familiy of UTAH/MORMON ethnicity. It is supplied by Corriell under catalogue number GM06990.
EFO_0002786	GM12892	A cell line derived from human female B cells.
EFO_0002787	GM18507	A cell line derived from human male lymphoblasts.
EFO_0002788	GM19238	A cell line derived from human female B cells.
EFO_0002789	GM19239	A cell line derived from human male B cells.
EFO_0002790	GM19240	A cell line derived from human female B cells.
EFO_0002792	HGF	A cell line derived from human normal fibroblasts.
EFO_0002793	HL-60	HL-60 is a cell line which is the bearer of human acute myeloid leukemia established from the peripheral blood of a 35-year-old woman with acute myeloid leukemia (AML FAB M2) in 1976.
EFO_0010756	HL-60/S4	HL-60/S4 is a subline of the HL-60 cell line. The HL-60/S4 cell line was established in 1992 and is supersensitive to retinoic acid.
EFO_0002797	LHSR	LHSR is a cell line in which human prostate epithelial cells (PrEC) were infected with amphotropic retroviruses encoding the SV40 large T antigen (L), the telomerase catalytic subunit hTERT (H), the SV40 small T antigen (S) and an oncogenic allele of H-ras (R) to create LHSR cells.
EFO_0002810	1205-Lu	A cell line derived from human melanoma.
EFO_0002815	BJAB	The malignant human B-cell-line BJAB is a EBV-negative Burkitt-like lymphoma cell line.
EFO_0002818	CADO ES1	A cell line derived from human 39 s sarcoma.
EFO_0002824	HCT116	Human colon carcinoma cell line; established from the primary colon carcinoma of an adult man.
EFO_0002827	LC-1F	A cell line derived from human squamous cell lung carcinoma.
EFO_0002830	MKN1	Human gastric adenosquamous carcinoma cell line.
EFO_0002831	MKN28	Well differentiated human gastric adenocarcinoma cell line.
EFO_0002832	MKN45	Human gastric adenocarcinoma, established from the poorly differentiated adenocarcinoma of the stomach (medullary type) of a 62-year-old woman.
EFO_0002839	MSTO-211H	Human mesothelioma cell line; established from the pleural effusion of a 62-year-old Caucasian man with mesothelioma (malignant biphasic) who did not have any prior therapy.
EFO_0002853	RM 82	A cell line derived from human 39 s sarcoma.
EFO_0002854	SBC-3	A cell line derived from human small cell lung carcinoma.
EFO_0002895	MKN7	Well differentiated human gastric adenocarcinoma cell line.
EFO_0002957	2102Ep	2102ep is an embryonal cell line
EFO_0002959	NTera2	A human embryonal carcinoma (EC) stem cell line used as a model system for the study of neuronal differentiation
EFO_0002960	BG03	A human embryonic stem cell line
EFO_0002961	NTera2 derived dopaminergic neuronal like cells	A human embryonal carcinoma (EC) stem cell line used as a model system for the study of neuronal differentiation and differentiated into neuronal like cells
EFO_0003039	EAhy 926 cell	The EAhy 926 cell is a hybridoma line derived from human endothelium and A549/8 cells. They display stable endothelial characteristics and may provide an indication of how endothelial cells respond to photodynamic therapy.
EFO_0003042	H1-hESC	H1 human embryonic stem cell line, usually called H1-hESC and on occasion just H1
EFO_0003045	H9	"This human ES cell line expresses cell surface markers specific to undifferentiated nonhuman primate ES and human EC cells: stage-specific embryonic antigen (SSEA)–3, SSEA-4, TRA-l-60, TRA-1- 81, and alkaline phosphatase. It has a normal 46, XX karyotype. Teratomas are formed upon cell injection into SCID mice. These teratomas include cells from all three germ layers.

Isolation & Growth Conditions
This cell line can be cultured using feeder cells or in a feeder-free protocol. When using feeder cells, human ESC culture medium should be compreised of Advanced DMEM/F12 supplemented with knockout serum replacement (20%), non-essential amino acids (1x), L-glutamine (1x), penicillin/streptomycin (1x), β-mercaptoethanol (1x) and FGF-2 (4 ng/ml). Maintain the human ESCs on Matrigel using hESC medium conditioned by mouse embryonic fibroblasts."
EFO_0003056	M14	The human melanoma cell line M14 has been established from surgically removed melanoma metastases.
EFO_0004389	UCH-1	Human chordoma cell line.
EFO_0004921	GM00038	Apparently health human non-fetal tissue.
EFO_0004922	GM00719	ATAXIA-TELANGIECTASIA; AT
EFO_0005231	ECC-1	An established epithelial cell line derived from an adenocarcinoma of human endometrial lining.
EFO_0005234	PFSK-1	Neuroectodermal cell line derived from a cerebral brain tumor.
EFO_0005236	NT2/D1	 The NTERA-2 cl.D1 cell line is a pluripotent human testicular embryonal carcinoma cell line derived by cloning the NTERA-2 cell line. Derived from metastatic site: lung
EFO_0005237	U-87 MG	A human epithelial cell derived from subject with grade IV glioblastoma; astrocytoma.
EFO_0005263	TOV-112D	TOV-112D is a human epithelial cell line initiated in October of 1992 from a patient with early onset ovarian cancer. The patient was of French-Canadian descent with an unknown family history of ovarian cancer.
EFO_0005264	Ect1	The ectocervical Ect1/E6E7 (ATCC CRL-2614) and endocervical End1/E6E7 (ATCC CRL-2615) cell lines were established in 1996 from normal epithelial tissue taken from a premenopausal woman undergoing hysterectomy for endometriosis.
EFO_0005265	MOLT-3	MOLT-3 is a male human malignant T-lymphoblastic cell line.
EFO_0005282	HS-5	Established from human bone marrow stromal cells transformed by HPV-16 E6/E7.
EFO_0005283	HS-27A	Established from human bone marrow stromal cells transformed by HPV-16 E6/E7.
EFO_0005355	HUES1	A human embryonic stem cell line
EFO_0005384	HuH-7	HuH-7 is a well differentiated hepatocyte derived cellular carcinoma cell line that was originally taken from a liver tumor in a 57-year-old Japanese male in 1982. The line was established by Nakabayshi, H. and Sato, J. HuH-7 is an immortal cell line of epithelial-like tumorigenic cells. It usually grow in 2D monolayers.
EFO_0005388	JIMT-1	"Source : Pleural effusion, Ductal breast cancer (grade 3 invasive, T2N1M0)
Karyotype : Highly rearranged hyperdiploid karyotype with 6% polyploidy
Carry an amplified HER-2 oncogene and to be insensitive to HER-2-inhibiting drugs"
EFO_0005441	DU 145	A cell line derived from human prostate carcinoma. The patient was a 69-year-old male, and the sample was derived from brain metastasis.
EFO_0005445	PEO1	PEO1 is an adherent cell line derived from a malignant effusion from the peritoneal ascites of a patient with a poorly differentiated serous adenocarcinoma. The patient previously received cisplatin, 5-fluorouracil and chlorambucil treatment. PEO1 is tumourigenic in immunologically-deprived CBA mice. PEO1 exhibits good growth in semi-solid medium (agar). PEO1 is from the same patient as the PEO4 and PEO6 cell lines (Sigma Catalogue numbers 10032309 & 10032310).This cell line is one of nine from the PE ovarian adenocarcinoma panel (derived from 4 patients at varying stages of ovarian cancer, isolated from various malignant sites, and at various treatment stages) available at ECACC which provides a model system for research into the mechanism of oestrogen action on ovarian adenocarcinoma tumour cells, and for the study of efficacy and toxicity of oestrogen protagonists. (Sigma-Aldrich catalog number 10032308)
EFO_0005696	D721Med	Medulloblastoma (aka D721), surgical resection from a patient with medulloblastoma as described by Darrell Bigner (1997)
EFO_0005697	M059J	M059J cells were isolated from a tumor specimen taken from a 33 year old male with untreated malignant glioblastoma. The cells were isolated concurrently from the same tumor specimen as M059K (see CRL-2365).
EFO_0005698	Daoy	The Daoy cell line was established in 1985 by P. F Jacobsen of the Royal Perth Hospital in Western Australia. The line was derived from biopsy material taken from a tumor in the posterior fossa of a 4 year old boy.
EFO_0005700	TTC549	This is an adherent cell line derived from a hepatic rhabdoid tumor. Hepatic rhabdoid tumors are extremely rare. This cell line has a large deletion on 22q, which indicates numerous genes in addition to SNF5 are deleted.
EFO_0005702	A204.1	A malignant rhabdoid tumor diploid cell population cloned from the A204 ATCC cell line. [PMID: 16897758]
EFO_0005703	G401.6	This is an adherent cell line that represents the prototypical renal rhabdoid tumor [PMID: 16897758]. G401.6 is a diploid, 6-thioguanine-resistant clonal variant of the G401 cell line isolated by Weissman et al., Science, 236:175-180 (1986). The parental cell line, G401, can be ordered from the ATCC (CRL1441).
EFO_0005704	HuH-7.5	HuH-7 is a well differentiated hepatocyte derived cellular carcinoma cell line that was originally taken from a liver tumor in a 57-year-old Japanese male in 1982. The line was established by Nakabayshi, H. and Sato, J. HuH-7 is an immortal cell line of epithelial-like tumorigenic cells. It usually grow in 2D monolayers. HuH7.5 developed from HuH7.
EFO_0005705	olfactory neurosphere cell line	Nasal biopsies were collected from volunteer donors as an outpatient procedure as described (Feron et al., 1998). This was done by a registered otolaryngologist via an endoscopic procedure to ensure biopsy samples were taken from the superior, posterior region of the nasal septum close to the cribriform plate. Pieces of olfactory mucosa were obtained which contain stem cells in the olfactory epithelium. The stem cell population derived from human olfactory mucosa has been described as ecto-mesenchymal (Delorme et al., 2010) because it has characteristics of both neural and mesenchymal stem cells, suggesting a neural crest origin.
EFO_0009494	C1 100080002	Cell line from olfactory neurosphere cells from a 59-year-old human male.
EFO_0009495	C1 100080003	Cell line from olfactory neurosphere cells from a 66-year-old human female.
EFO_0009496	C1 100080013	Cell line from olfactory neurosphere cells from a 64-year-old human male.
EFO_0005706	Mel-2183	" in the Surgery Branch of the NCI."">This cell line was from a melanoma metastasis tumor taken from the subcutaneous shoulder of an individual. Cell line was derived by Dr. Yardena Samuels (samuelsy[at]mail.nih.gov)"
EFO_0005707	786-0	This line was derived from a primary clear cell adenocarcinoma. The karyotype is hypertriploid; Y was present in 60% the cells examined. The cells display both microvilli and desmosomes, and can be grown in soft agar. The cells produce a PTH like peptides that is identical to peptides produced by breast and lung tumors.
EFO_0005709	HTR8/SVneo	First trimester human trophoblast cells established by immortalizing a physiologic extravillous trophoblast cell via transfection with a plasmid containing the simian virus 40 large T antigen (SV40) (see Graham et al., 1993). Cells are a thin layer of ectoderm that forms the wall of many mammalian blastulas and functions in the nutrition and implantation of the embryo.
EFO_0005710	HFF-Myc	This is an adherent cell line. HFF-Myc are human foreskin fibroblasts containing a virally integrated vector expressing the canine cMyc gene. Cells were received from Dr. Beverly Torok-Storb, Fred Hutchison Cancer Research Center, Seattle, WA.
EFO_0005711	HPDE6-E6E7	Normal benign adult human pancreatic duct cells immortalized with E6E7 gene of HPV-16. HPDE6-E6E7 cells demonstrated a near normal genotype and phenotype of pancreatic duct epithelial cells. [PMC1861644]
EFO_0005712	RPMI-7951	Human skin malignant melanoma cells that can be ordered from ATCC. This is a hyperdiploid human cell line with the modal chromosome number of 49, occurring in 24% of cells. Polyploid cells occurred at 22%, which is high. Cells are adherent, and were first harvested in 1971 from a metastatic site in a lymph node.
EFO_0005713	8988T	"Human pancreas adenocarcinoma (PA-TU-8988T), ""established in 1985 from the liver metastasis of a primary pancreatic adenocarcinoma from a 64-year-old woman; sister cell line of PA-TU-8988S"" - DSMZ."
EFO_0005714	LHCN-M2	"Skeletal myoblasts derived from satellite cells from the pectoralis major muscle of a 41 year old caucasian heart transplant donor, immortalized with lox-hygro-hTERT (LH), and Cdk4-neo (CN), Zhu et al. (2007) in Aging Cell, vol. 6, pp 515-523. M2 is an extremely well-differentiating subclone of LHCN (thus ""LHCN-M2"")."
EFO_0005715	WERI-Rb-1	The WERI-Rb-1 line is one of two human retinoblastoma cell lines established in 1974 by R.M. McFall and T.W. Sery. This is a near diploid line. The modal chromosome number is 47 occurring at 38%, and the rate of polyploidy is 9%. Cells are grape-like clusters of round cells in suspension.
EFO_0005718	Ishikawa	"""The cell line Ishikawa was established from an endometrial adenocarcinoma of a 39 year old woman. Cells can be commercially obtained from Sigma (99040201-1VL). However, it should be noted that the original source of these cells (M. Nashide, Japan) can spontaneously lose the progesterone and
estrogen receptor. For details, see Nishida M., The Ishikawa cells from birth to the
present. Hum Cell. 2002 Sep;15(3):104-17."""
EFO_0005720	SK-MEL-5	This melanoma cell line was derived from a metastatic axillary node of the skin of a 24 year old female. It is a hyperpentaploid human cell line with the modal chromosome number of 120, occurring in 9% of cells. [PMID: 1067619]
EFO_0005721	SK-N-DZ	SK-N-DZ is a neuroblastoma cell line derived in 1978 from a bone marrow metastasis from a child with poorly differentiated embryonal neuroblastoma.
EFO_0005722	SJRH30	The line was established from cells from the bone marrow of a child with rhabdomyosarcoma. Derived from a metastatic site of the bone marrow. The cells show ultrastructural elements of primitive skeletal muscle differentiation.
EFO_0005723	GM23248	Fibroblasts taken from a skin punch of the arm
EFO_0005724	MM.1S	MM.1S is a B lymphoblast cell line derived in 1986. The parent cell line, MM.1, was established from peripheral blood of a multiple myeloma patient who had become resistant to steroid-based therapy. provide critical information about disease progression and the development of drug resistance. This cell line represents a valuable tool for elucidating the mechanisms of action of glucocorticoids and the development of new therapeutics. [PMID: 2926241]
EFO_0005725	BE(2)-C	BE(2)-C is a clone of the SK-N-BE(2) neuroblastoma cell line (ATCC CRL-2271) that was established in November of 1972 from a bone marrow biopsy taken from child with disseminated neuroblastoma after repeated courses of chemotherapy and radiotherapy. The cells grow as clusters of flattened neuroblastic cells with occasional fine cell processes (neurites). Unlike the parent line, they generally do not detach and float.
EFO_0005726	LNCaP clone FGC	LNCaP clone FGC was isolated in 1977 by J.S. Horoszewicz, et al., from a needle aspiration biopsy of the left supraclavicular lymph node of a 50-year-old Caucasian male (blood type B+) with confirmed diagnosis of metastatic prostate carcinoma. This is a hypotetraploid human cell line. The modal chromosome number was 84, occurring in 22% of cells. However, cells with chromosome counts of 86 (20%) and 87 (18%) also occurred at high frequencies. These cells are responsive to 5-alpha-dihydrotestosterone (growth modulation and acid phosphatase production).
EFO_0005901	ELF-1	Human embryonic stem cell line ELF-1 was derived from a human embryo in the Ellison Stem Cell Core at the University of Washington, Seattle, WA.
EFO_0005903	KBM-7	KBM-7 cells were derived from a 39-year-old man with chronic myeloid leukemia in blast crisis. The original cell line contained both near haploid and hyperdiploid clones. Subsequent subcloning yielded a pure near-haploid cell line.Genome analysis has revealed that besides the disomic chromosome 8 also a 30 megabase fragment of chromosome 15 is present in two copies. Like other CML cells lines (e.g., K562) KBM-7 cells are positive for the Philadelphia chromosome harboring the BCR-ABL oncogenic fusion. KBM-7 cells have been reprogrammed to yield the HAP1 cell line which is also haploid for chromosome 8.
EFO_0007598	HAP-1	HAP1 is a near-haploid human cell line that was derived from the male chronic myelogenous leukemia (CML) cell line KBM-7. HAP1 cells are adherent with fibroblast-like morphology.
EFO_0005904	H7-hESC	Undifferentiated embryonic stem cells
EFO_0005907	OCI-LY1	Established from the bone marrow of a 44-year-old man with B-cell Non-Hodgkin lymphoma (B-NHL; diffuse large cell), stage 4B at relapse in 1983.
EFO_0005909	HGADFN167	Dermal fibroblasts from an 8 year old male with Hutchinson-Gilford progeria syndrome (cell line HGPS, HGADFN167, progeria research foundation).
EFO_0005912	hTERT-HM	An immortalized cell line from hTERT-infected myometrial cells (hTERT-HM). Cells were isolated from myometrial tissue obtained from women undergoing hysterectomy, and retroviral infection was used to express the catalytic subunit of telomerase in myometrial cells.
EFO_0005913	urothelium cell line	Primary ureter cell culture of urothelial cells derived from a 12 year-old girl and immortalized by transfection with a temperature-sensitive SV-40 large T antigen gene.
EFO_0006268	A431	The epidermoid carcinoma cell line A-431, derived from an 85-year-old female, is one of a series of cell lines established from solid tumors by D.J. Giard, et al. This is a hypertriploid human cell line. The modal chromosome number was 74 occurring in 36% of cells. The rate of cells with higher ploidies was 1.0%.
EFO_0006269	ACH-3P	Cell line was established by fusion of primary human first trimester trophoblasts (week 12 of gestation) with a human choriocarcinoma cell line (AC1-1).
EFO_0006270	AG04450	The culture was initiated on 5/20/80 from explants of minced lung tissue taken from a therapeutically aborted fetus of 12 weeks gestational age. The cell morphology is fibroblast-like. The karyotype is 46,XY; normal diploid male. A matched skin-derived fibroblast culture from same fetus is AG04449.
EFO_0006271	ARPE-19	ARPE-19 is a spontaneously arising retinal pigment epithelia (RPE) cell line derived in 1986 by Amy Aotaki-Keen from the normal eyes of a 19-year-old male who died from head trauma in a motor vehicle accident.
EFO_0006276	GM15850	Clinically affected; ataxia; scoliosis; hypertrophic cardiomyopathy; slurred speech; homozygous for the GAA expansion in the frataxin gene with alleles of approximately 650 and 1030 repeats; brother of GM15849 and GM15851, son of GM15847 and GM15848.
EFO_0006277	GM15851	Clinically unaffected;has two FRDA alleles in the normal range of GAA trinucleotide repeats;brother of an affected individual (GM15850).
EFO_0006278	GM5659	GM5659 primary fibroblasts were established from a skin biopsy of an apparently healthy donor
EFO_0006279	HPAF1	Cell line is derived from the normal human parotid gland. The cell lines are propagated in serum-free medium comprised of keratinocyte basal medium supplemented with insulin (5 micrograms/ml), hydrocortisone (0.5 micrograms/ml),epidermal growth factor (EGF, 10 ng/ml), bovine pituitary extract (25 micrograms/ml), and antibiotics. Normal diploid karyotypes, lack transformed phenotypes and non-tumorigenic in nude mice. Produces tissue-specific proteins, i.e. α-amylase 1, basic proline-rich protein, and cystatins; and expressed the corresponding genes as determined by RT-PCR analyses.
EFO_0006280	HPAM1	Cell line is derived from the normal human parotid gland. The cell lines are propagated in serum-free medium comprised of keratinocyte basal medium supplemented with insulin (5 micrograms/ml), hydrocortisone (0.5 micrograms/ml),epidermal growth factor (EGF, 10 ng/ml), bovine pituitary extract (25 micrograms/ml), and antibiotics. Normal diploid karyotypes, lack transformed phenotypes and non-tumorigenic in nude mice. Produces tissue-specific proteins, i.e. α-amylase 1, basic proline-rich protein, and cystatins; and expressed the corresponding genes as determined by RT-PCR analyses.
EFO_0006281	JinB8	CD47-deficient T cell line derived from Jurkat cells (JinB8)
EFO_0006282	KM12	KM12 is one of the cell lines of the NCI-60 panel which represents different cancer types and has been widely utilized for drug screening and molecular target identification.
EFO_0006285	MEC2	Cell line grew spontaneously on two subsequent occasions from the peripheral blood (PB) of a patient with B-chronic lymphocytic leukemia (B-CLL) in prolymphocytoid transformation. The patient was EBV-seropositive, his leukemic cells were EBNA negative, but the spontaneously grown cell lines are EBNA-2 positive. MEC2 cells do not adhere and form large clumps. The doubling time of MEC2 is 31h.
EFO_0006287	Mono Mac 6	A monocytic cell line, termed Mono Mac, was established from peripheral blood of a patient with monoblastic leukemia. Two clones, designated Mono Mac I and Mono Mac 6, were isolated and both were assigned to the monocyte lineage on the basis of morphological, cytochemical and immunological criteria. Most importantly, the clones express NaF-sensitive non-specific-esterase, produce reactive oxygen and stain with MAb My4. Mono Mac 6, in addition, constitutively exhibits phagocytosis of antibody-coated erythrocytes in 80% of the cells and reacts with a panel of MAbs that are specific for mature monocytes, i.e., M42, LeuM3, 63D3, Mo2 and UCHMI. By contrast, the monoblastic cell lines U937 and THP-I are negative for all these markers. Only expression of My4 could be detected after differentiation induced by interferon-gamma (IFN-gamma). Similar treatment of Mono Mac I, however, resulted in staining with all the monocyte-specific MAbs mentioned above, while IFN-gamma treatment of Mono Mac 6 enhanced antigen expression. In addition, the cells showed an increased frequency of multinucleated cells with a rise from 4.8% to 21.9%. Mono Mac 6 appears to be the only one of the cell lines studied to constitutively express phenotypic and functional features of mature monocytes.
EFO_0006294	SHEP	SH-EP is derived from SK-N-SH cell line. Cells of SH-EP are flattened in shape and do not have neuritic processes.
EFO_0006296	STS26T	STS26T cells were derived from a sporadic MPNST and have functional neurofibromin
EFO_0006304	T265	The T265 cell line is widely used for cell culture studies of Schwann cells in MPNSTs. This cell line has characteristics consistent with Schwann cells that have been transformed into a malignant phenotype because of the loss of neurofibromin in the auto-somal-dominant condition NF1
EFO_0006354	105KC	Human chondrosarcoma cell line.
EFO_0006355	143B	Human osteosarcoma cell line. ATCC catalog number CRL-8308
EFO_0006358	59M	Human ovarian carcinoma cell line. (Sigma-Aldrich catalog number 89081802)
EFO_0006362	A2780	Human ovarian carcinoma cell line. (Sigma-Aldrich catalog number 93112519)
EFO_0006364	C32	Human melanoma cell line. ATCC catalog number CRL-1585
EFO_0006365	C4-2B	Human prostate cancer cell line derived from subcutaneous LNCaP xenografts in castrated nude mice.
EFO_0006366	CAL 27	Human squamous cell carcinoma cell line
EFO_0006373	COLO 680N	Human squamous cell carcinoma cell line (DSMZ catalog number ACC 182)
EFO_0006376	COLO 783	Human melanoma cell line (DSMZ catalog number ACC257)
EFO_0006377	COLO 792	Derived from a brain metastasis of a 62 year old male with melanoma. The cells bleb during culture. (Sigma-Aldrich catalog number 93052616)
EFO_0006378	COLO 800	Derived from a subcutaneous nodule of a tumour from a 14-year-old male. Cells display remarkable blebbing. (Sigma-Aldrich catalog number 93051123)
EFO_0006379	COLO 849	derived in 1992 from right axillary lymph nodes of a 43-year-old Caucasian man with metastatic maligant melanoma (DSMZ catalog number ACC 216)
EFO_0006380	COLO 853	Derived from the right axilla lymph node of a 43 year old male with melanoma. (Sigma-Aldrich catalog number 93052606)
EFO_0006381	COLO 857	Derived from a right axilla lymph node of a 43 year old male with melanoma. The biopsy material was obtained post chemotherapy. (Sigma-Aldrich catalog number 93051120)
EFO_0006382	COV318	A human ovarian epithelial-serous carcinoma cell line established from a peritoneal ascites. Anchorage-independent growth in agar has been reported. (Sigma-Aldrich catalog number 07071903)
EFO_0006383	COV362	A human ovarian epithelial-endometroid carcinoma cell line established from a pleural effusion. Anchorage-independent growth in agar has been reported. (Sigma-Aldrich catalog number 07071910)
EFO_0006384	COV434	Human ovarian granulosa tumour cell line established from a solid primary tumour (Sigma-Aldrich catalog number 07071909)
EFO_0006385	COV504	A human ovarian epithelial-serous carcinoma cell line established from a pleural effusion. Anchorage-independent growth in agar has been reported. (Sigma-Aldrich catalog number 07071902)
EFO_0006386	COV644	Human ovarian epithelial-mucinous carcinoma cell line established from a solid primary tumour. Anchorage-independent growth in agar has been reported. (Sigma-Aldrich catalog number 07071908)
EFO_0006389	DLD1	Dukes' Type C, Colorectal Adenocarcinoma cell line. ATCC catalog number CCL-221
EFO_0006390	DMS 454	The small cell carcinoma DMS 454 was isolated in 1981 from lung tissue of a male patient at time of autopsy. (Sigma-Aldrich catalog number 95062832)
EFO_0006393	Farage	The Farage cell line was adapted to culture in 1990 from a lymph node biopsy of a patient with diffuse large cell non-Hodgkin's lymphoma (DLCL). (ATCC catalog number CRL-2630)
EFO_0006394	G-361	Human malignant melanoma cell line (ATCC catalog number CRL-1424)
EFO_0006395	G111	Human glioma cell line
EFO_0006396	G112	Human glioma cell line
EFO_0006397	G118	Human glioma cell line
EFO_0006398	G120	Human glioma cell line
EFO_0006399	G121	Human glioma cell line
EFO_0006400	G122	Human glioma cell line
EFO_0006401	G124	Human glioma cell line
EFO_0006402	G130	Human glioma cell line
EFO_0006403	G140	Human glioma cell line
EFO_0006404	G141	Human glioma cell line
EFO_0006405	G142	Human glioma cell line
EFO_0006406	G22	Human glioma cell line
EFO_0006407	G28T	Human glioma cell line
EFO_0006408	G44	Human glioma cell line
EFO_0006409	G59	Human glioma cell line
EFO_0006410	G61	Human glioma cell line
EFO_0006411	G84	Human glioma cell line
EFO_0006412	G96	Human glioma cell line
EFO_0006415	HCA-7	The human colon cancer cell line, HCA-7 Colony 29 expresses Cox-2. An interesting feature of this cell line is that it forms polarised epithelial sheets which allows examination of the trafficking and release of biomolecules in vitro. Cyclooxygenases (COXs) are key enzymes in the conversion of arachidonic acid to prostaglandins and other eicosanoids. It has been found that colonic polyps and cancers overexpress Cox-2 and that the inhibition of this enzyme by nonsteroidal anti-inflammatory drugs decreases the risk of colonic neoplasia. This cell line is useful for studying the role of Cox-2 in cancer cell biology and the investigation of colorectal epithelial cell polarity. Imperial College Innovations has stated that this cell line is not to be supplied to commercial organisations. (Sigma-Aldrich catalog number 02091238)
EFO_0006431	HCC2279	Human lung adenocarcinoma cell line from 52-year-old Asian female patient
EFO_0006438	HEp-2	Cells of this line contain HeLa marker chromosomes, and were derived via HeLa contamination. This line was originally thought to be derived from an epidermoid carcinoma of the larynx, but was subsequently found, based on isoenzyme analysis, HeLa marker chromosomes, and DNA fingerprinting, to have been established via HeLa cell contamination. The cells are positive for keratin by immunoperoxidase staining. ATCC confirmed this cell line is positive for the presence of human papilloma viral DNA sequences via PCR.
EFO_0006439	HOP62	Human non small cell lung carcinoma cell line
EFO_0006441	Hs 683	Human glioma cell line (ATCC catalog number HTB-138)
EFO_0006442	HT115	Human colon carcinoma cell line. Cells possess Ca antigen as defined by the Ca1 antibody. The Ca antigen has been shown to be absent in non-malignant human cell strains and is considered to be a marker linked with malignancy. Island cell growth will degenerate if left more than 9 days between passages. (Sigma-Aldrich catalog number 85061104)
EFO_0006443	HT144	Human malignant melanoma cell line derived from metastatis in subcutaneous tissue from a 29-year-old male Caucasian patient. (ATCC catalog number HTB-63)
EFO_0006444	HT55	Human colon carcinoma cell line (Sigma-Aldrich catalog number 85061105)
EFO_0006446	IM-95	Human adenocarcinoma cell line from a 63-year-old Japanese male patient with moderately differentiated adenocarcinoma of the stomach
EFO_0006448	JL-1	Human malignant epithelioid mesothelioma cell line established from the untreated malignant epithelioid mesothelioma of the pleura of a 54-year-old man with asbestos cancer in 2003 (DSMZ catalog number ACC 596)
EFO_0006451	M059K	M059K cells were isolated from a tumor specimen from a 33 year-old male patient with untreated glioblastoma. (ATCC catalog number CRL-2365)
EFO_0006454	MDA-MB-330	Human breast carcinoma cell line (ATCC catalog number HTB-127)
EFO_0006456	MS751	Human cervical epidermoid carcinoma cell line derived from metastatis in lymph node (ATCC catalog number HTB-34)
EFO_0006458	OV56	The OV56 cell line was established from ascitic fluid derived from a 46-year-old female patient diagnosed with ovarian cancer. The tumour was characterised as stage IV, poorly differentiated. Immunocytochemical staining of the cells was reported to show strong staining for cytokeratin (CK), weak staining for carcinoembryonic antigen (CEA) and strong staining for human milk fat globulin (HMFG-2). Production of vascular endothelial growth factor (VEGF) has been detected by ELISA. The patient had received sequential treatment with cisplatin and cyclophosphamide, cisplatin and etoposide and subsequently tamoxifen. (Sigma-Aldrich catalog number 96020759)
EFO_0006459	OV7	The OV7 cell line was established from solid ovarian tumour tissue taken from a 78-year-old female patient. The tumour was characterised as stage III, mixed tumour type and poorly differentiated. Immunocytochemical staining of the cells was reported to show strong staining for cytokeratin (CK), no staining for carcinoembryonic antigen (CEA) and strong staining for human milk fat globulin (HMFG-2). Detection of mRNA expression of vascular endothelial growth factor (VEGF) and its receptors flt and KDR has been reported. The patient had received treatment with chlorambucil. (Sigma-Aldrich catalog number 96020764)
EFO_0006465	PA-1	Human ovarian teratocarcinoma cell line derived from metastasis in ascites (ATCC catalog number CRL-1572)
EFO_0006466	Panc 02.03	Panc 02.03 is a pancreatic adenocarcinoma epithelial cell line derived in 1995 from a primary tumor removed from the head-of-the-pancreas of a female with pancreatic adenocarcinoma. (ATCC catalog number CRL-2553)
EFO_0006467	Panc 03.27	Panc 03.27 is a pancreatic adenocarcinoma epithelial cell line derived in 1995 from a primary tumor removed from the head-of-the-pancreas of a female with pancreatic adenocarcinoma. (ATCC catalog number CRL-2549)
EFO_0006468	Panc 04.03	Panc 04.03 is a pancreatic adenocarcinoma epithelial cell line derived, in 1995, from a primary tumor removed from the head-of-the-pancreas of a male with pancreatic adenocarcinoma. (ATCC catalog number CRL-2555)
EFO_0006469	Panc 05.04	Panc 05.04 is a pancreatic adenocarcinoma epithelial cell line derived, in 1995, from a primary tumor removed from the head-of-the-pancreas of a female with pancreatic adenocarcinoma. (ATCC catalog number CRL-2557)
EFO_0006470	Panc 08.13	Panc 08.13 is a pancreatic adenocarcinoma epithelial cell line derived in 1995 from a primary tumor removed from the head-of-the-pancreas of a male with pancreatic adenocarcinoma. (ATCC catalog number CRL-2551)
EFO_0006472	Pfeiffer	The Pfeiffer cell line was established in 1992 from a patient in the leukemic phase of diffuse large cell lymphoma (DLCL) with cleaved and non-cleaved nuclei. (ATCC catalog number CRL-2632)
EFO_0006474	PL45	PL45 is a pancreatic adenocarcinoma epithelial cell line derived in 1992 from a primary tumor removed from the pancreas of a man with poorly differentiated pancreatic adenocarcinoma of ductal origin. (ATCC catalog number CRL-2558)
EFO_0006476	RCM-1	Human colorectal adenocarcinoma cell line
EFO_0006478	RPMI 2650	Human squamous cell carcinoma derived from metastatis in pleural effusion (ATCC catalog number CCL-30)
EFO_0006479	RT-112	Human carcinoma cell line established from the transitional cell carcinoma (histological grade G2) excised from a woman (age unknown) with untreated primary urinary bladder carcinoma in 1973; described to form tumors in nude mice (DSMZ catalog number ACC 418)
EFO_0006480	RT4	Human transitional cell papilloma cell line (ATCC catalog number HTB-2)
EFO_0006481	SC-1	Human B-cell lymphoma cell line from a 67-year-old male patient
EFO_0006490	SK23	Human melanoma cell line
EFO_0006492	SU-DHL-4	Human lymphoma cell line isolated from peritoneal effusion in a 38-year-old male Caucasian patient. (ATCC catalog number CRL-2957)
EFO_0006493	SU-DHL-8	Human large cell lymphoma cel line derived from peritoneal effusion in a 59-year-old male Caucasian patient (ATCC catalog number CRL-2961).
EFO_0006494	SU.86.86	Human pancreatic ductal carcinoma derived from metastasis in liver. (ATCC catalog number CRL-1837)
EFO_0006496	TMD8	Human diffuse large B cell lymphoma cell line derived from a 62-year-old male patient.
EFO_0006498	U-251 MG	Human glioblastoma cell line (Sigma-Aldrich catalog number 09063001)
EFO_0006499	U-2932	Human diffuse large B cell lymphoma cell line established in 1996 from the ascites of a 29-year-old woman with diffuse large B cell lymphoma, who 16 years earlier was diagnosed with advanced stage Hodgkin lymphoma, and relapsed several times after multiple chemo- and radiotharapy regimens to complete remissions; cells were described to overexpress BCL2, BCL6 and p53; assigned to ABC-like lymphoma subtype (activated B-cell) (DSMZ catalog number ACC 633)
EFO_0006528	23132/87	human gastric adenocarcinoma cell line established from the primary tumor of a 72-year-old man with gastric adenocarcinoma in 1987 confirmed as human with IEF of AST, MDH
EFO_0006531	888-mel	human melanoma cell line designated 888-mel has been developed from the resected tumor of a 26-year old Caucasian female (patient 888) diagnosed with metastatic melanoma - See more at: https://ttc.nci.nih.gov/opportunities/opportunity.php?opp_id=34826089312#sthash.to7UCByK.dpuf
EFO_0006532	A3/KAW	human lymphoma cell line from a 68 year old female Japanese patient with stomach cancer and lymphoma
EFO_0006533	A4/Fuk	human lymphoma cell line from a 52 year old female Japanese patient with malignant melanoma
EFO_0006534	AMO-1	human plasmacytoma cell line from a 64 year old female patient (DSMZ catalog number ACC 583)
EFO_0006535	ATRFLOX	human colorectal carcinoma cell line from an adult male patient (ATCC CRL-2780)
EFO_0006537	BEN	human carcinoma cell line established from the supraclavicular tumor cells-containing lymph node of a 71-year-old man with poorly differentiated carcinoma of the lung (DSMZ calatog number: ACC 254)
EFO_0006538	BFTC-909	human cell carcinoma established from the sarcomatoid component of a grade III transitional cell carcinoma of the renal pelvis of a 64-year-old man in 1990; patient lived in a blackfoot disease endemic area in Taiwan (DSMZ catalog number ACC 367)
EFO_0006539	BHY	human oral squamous cell carcinoma established from the tumor of a 52-year-old Japanese man with highly differentiated squamous cell carcinoma of the lower alveolus which was highly invasive to the mandibular bone and the muscle layer of the oral floor (DSMZ catalog number ACC 404)
EFO_0006540	BICR 10	human recurrent squamous cell carcinoma of the buccal mucosa of a Caucasian female (Sigma catalog number 04072103)
EFO_0006541	BICR 22	human cell line derived from a lymph node metastasis squamous cell carcinoma of the tongue of a Caucasian male (Sigma catalog number 04072106)
EFO_0006542	BICR 31	human cell line derived from a lymph node metastasis squamous cell carcinoma of the tongue of a Caucasian male (Sigma catalog number 04072107)
EFO_0006543	BICR 78	human cell line derived from a squamous cell carcinoma of the oral alveolus of a Caucasian male (Sigma catalog number 04072111)
EFO_0006546	C2BBe1	human colorectal carcinoma cell line from a 72 year old male patient (ATCC CRL-2102)
EFO_0006547	CAL-12T	human cell lung carcinoma line established from a male patient with a non-small cell lung carcinoma in 1981 (DSMZ catalog number ACC 443)
EFO_0006548	CaR-1	human rectal carcinoma cell line establish from a metastatic lymph node of a 70-year-old male patient with primary rectal adenocarcinoma
EFO_0006549	CaSki	human cervical epidermoid carcinoma cell line from a 40 year old female Caucasian patient (ATCC CRL-1550)
EFO_0006550	CCRF-SB	human lymphoma cell line from a 11.5 year old male Caucasian patient (ATCC CCL-120)
EFO_0006551	CFPAC-1	human ductal pancreatic adenocarcinoma derived by differential trypsinisation of explant cultures from a metastatic lesion in the liver of a 26 year old caucasian male with cystic fibrosis (Sigma catalog number 91112501)
EFO_0006552	CMA-03	human myeloma cell line derived from a peritoneal effusion of a patient with refractory myeloma
EFO_0006553	CMA-03/06	human myeloma cell line derived from CMA03
EFO_0006554	COLO 206F	human colon adenocarcinoma cell line established from the ascites fluid obtained from a 70-year-old male patient with adenocarcinoma of the colon (Sigma catalog number 93052620)
EFO_0006555	COR-L26	human large cell lung cancer bone marrow aspirate derived cell line established from a female patient (Sigma catalog number 96020740)
EFO_0006556	COR-L47	human lung cancer cell line derived from the bone marrow aspirate of a 67-year-old Caucasian male suffering from small cell lung carcinoma (Sigma catalog number 92031915)
EFO_0006557	COV413A	human ovarian epithelial-serous carcinoma cell line established from a metastasis of the sigmoid colon (Sigma catalog number 07071905)
EFO_0006558	COV413B	human ovarian epithelial-serous carcinoma cell line established from an intraperitoneal metastasis of the bladder dome (Sigma catalog number 07071906)
EFO_0006559	CPC-N	human small lung carcinoma cell line established from the pleural effusion metastasis of a patient with small cell lung carcinoma in 1987 (DSMZ catalog number ACC 306)
EFO_0006560	CW-2	human colon carcinoma cell line
EFO_0006561	CX-1	human colon adenocarcinoma cell line established from the tumor tissue of a 44-year-old woman with well-differentiated colon adenocarcinoma in 1984 (DSMZ catalog number ACC 129)
EFO_0006562	DAN-G	human pancreas carcinoma cell line established from a human individual with pancreas carcinoma in 1985 (DSMZ catalog number ACC 249)
EFO_0006563	DEOC-1	human malignant melanoma cell line established from the heel lesion of a 59-year-old Japanese man
EFO_0006564	DOK	human dysplastic oral keratinocyte cell line isolated from a piece of dorsal tongue from a 57 year old Caucasian man (Sigma catalog number 94122104)
EFO_0006565	DV-90	human lung adenocarcinoma established from the pleural effusion of a stage IV lung adenocarcinoma
EFO_0006568	EFM-192A	human breast carcinoma cell line established from the pleural effusion of the left side (14 days after EFM-192A) of a 46-year-old Caucasian woman with breast adenocarcinoma (DSMZ catalog number ACC 311)
EFO_0006569	EFM-192B	human breast carcinoma cell line established from the pleural effusion of the left side (14 days after EFM-192A) of a 46-year-old Caucasian woman with breast adenocarcinoma (DSMZ catalog number ACC 308)
EFO_0006570	EFM-192C	human breast carcinoma cell line human breast carcinoma cell line established from the pleural effusion of the left side from a 46-year-old Caucasian woman with metastasizing breast adenocarcinoma in 1985 (DSMZ catalog number ACC 258)
EFO_0006571	EFO-27	human ovarian adenocarcinoma cell line established from the solid omental metastasis of a mucinous papillary adenocarcinoma of the ovary of a 36-year-old woman in 1979 (DSMZ catalog number ACC 191)
EFO_0006572	EJM	human multiple myeloma cell line established from the peritoneal fluid of a 58-year-old woman with IgG lambda myeloma in 1988 at her terminal refractory stage (DSMZ catalog number ACC 560)
EFO_0006573	EPLC-272H	human lung adenocarcinoma cell line established from a surgical lung specimen of a 57-year-old Caucasian man who underwent surgery for undifferentiated squamous cell carcinoma of the lung (without having received prior radiation or chemotherapy) in 1986 (DSMZ catalog number ACC 383)
EFO_0006574	EVSA-T	human breast carcinoma cell line established from the malignant ascitic effusion from a woman with metastatic breast carcinoma; described as being estrogen receptor-negative and progesterone receptor-positive (DSMZ catalog number ACC 433)
EFO_0006575	GP2d	human colon adenocarcinoma cell line derived from a local recurrence of Duke′s grade B, poorly differentiated carcinoma of the colon from a 71 year old female at surgical resection (SIgma catalog number 95090714)
EFO_0006576	GP5d	human colon adenocarcinoma cell line derived from a local recurrence of Duke′s grade B, poorly differentiated carcinoma of the colon from a 71 year old female at surgical resection (SIgma catalog number 95090715)
EFO_0006577	GR-M	human melanoma obtained from the thorax of a 36 year old male with skin metastases having received no treatment at the time of the biopsy (Sigma catalog number 95032301)
EFO_0006578	GTL-16	human gastric carcinoma cell line with amplification of the MET oncogene (Motoyama et al., 1986)
EFO_0006579	HEL	Human erythroleukemia, established from the peripheral blood of a 30-year-old man with erythroleukemia (AML M6) in relapse (after treatment for Hodgkin's disease) in 1980; cells were described to be capable of spontaneous and induced globin synthesis
EFO_0006580	HEY	human ovarian carcinoma cell line was derived from a human ovarian cancer xenograft (HX-62) originally grown from a peritoneal deposit of a patient with moderately differentiated papillary cystadenocarcinoma of the ovary (catalog number AKR-205)
EFO_0006581	HGC-27	human gastric carcinoma cell line established by culture of the metastatic lymph node from a gastric cancer patient diagnosed histologically as undifferentiated carcinoma
EFO_0006582	HMY-1	human melanoma cell line established from metastasised lymph node of a 62 year old Japanese man
EFO_0006583	HNT-34	human acute myeloid leukemia cell line established in 1994 from the peripheral blood of a 47-year-old woman with acute myeloid leukemia (AML FAB M4) secondary to previous myelodysplastic syndromes (MDS), specifically chronic myelomonocytic leukemia (CMML) (DSMZ catalog number ACC-600)
EFO_0006584	Hs 255.T	human colon adenocarcinoma cell line from a 46 year old Caucasian woman (ATCC CRL-7213)
EFO_0006585	Hs 294T	human melanoma cell line from a 56 year old Caucasian male (ATCC HTB-140)
EFO_0006586	Hs 38.T	human ovarian teratoma cell line from a female (ATCC CRL-7826)
EFO_0006587	Hs 675.T	human colorectal cancer cell line from a Caucasian male (ATCC CRL-7400)
EFO_0006588	Hs 695T	human melanoma cell line from a 26 year old Caucasian male (ATCC HTB-137)
EFO_0006589	Hs 746T	human gastric carcinoma cell line from a 74 year old Caucasian male (ATCC HTB-135)
EFO_0006590	Hs 766T	human pancreatic carcinoma from a 46 year old Caucasian male (ATCC HTB-134)
EFO_0006591	Hs 839.T	human melanoma cell line from a 42 year old Caucasian female (ATCC CRL-7572)
EFO_0006592	Hs 852.T	human melanoma cell line from a 53 year old Asian male (ATCC CRL-7585)
EFO_0006593	Hs 895.T	human melanoma cell line from a 48 year old Caucasian female (ATCC CRL-7637)
EFO_0006594	Hs 936.T	human melanoma cell line from a male (ATCC CRL-7686)
EFO_0006595	Hs 940.T	human melanoma cell line from a 57 year old Caucasian male (ATCC CRL-7691)
EFO_0006596	HuP-T3	human pancreatic adenocarcinoma cell line derived from an ascites sample taken from a 66 year old Japanese male with a poorly differentiated pancreatic adenocarcinoma (Sigma catlaog number 93121055)
EFO_0006597	IGR-37	human melanoma established from the lymph node metastasis (groin) of a 26-year-old man with malignant melanoma (primary tumor histology: SSM level IV) (DSMZ catalog number ACC 237)
EFO_0006598	IM95m	human stomach adenocarcinoma cell line from a 63 year old Japanese male with moderately differentiated adenocarcinoma of stomach
EFO_0006599	JHH-1	human hepatocellular carcinoma cell line from a 50 year old Japanese male with complication of hepatic cirrhosis and hepatocellular carcinoma
EFO_0006600	JHH-2	human hepatocellular carcinoma cell line from a 57 year old Japanese male with hepatocellular carcinoma
EFO_0006601	JHH-4	human hepatocellular carcinoma cell line from a 51 year old Japanese male with hepatocellular carcinoma
EFO_0006602	JHH-5	human hepatocellular carcinoma cell line from a 50 year old male with small liver cancer observed in the chronic hepatitis
EFO_0006603	JHH-7	human hepatocellular carcinoma cell line from a 53 year old male with HBs-Ag positive hepato cellular carcinoma (Ed.III) with liver cirrhosis
EFO_0006604	JJ012	human chondrosarcoma cell line
EFO_0006605	JJN-3	human leukemia cell line established from the bone marrow of a 57-year-old woman with plasma cell leukemia (IgA1kappa) at diagnosis in 1987 (DSMZ catalog number ACC 541)
EFO_0006606	KARPAS 1106P	human B-cell lymphoma cell line established from a pleural effusion of a 23 year old women with mediastinal lymphoblastic B-cell non-Hodgkin′s lymphoma (Sigma catalog number 06072607)
EFO_0006607	Kasumi-1	human acute myeloid leukemia cell line established from the peripheral blood of a 7-year-old Japanese boy with acute myeloid leukemia (AML FAB M2) (in 2nd relapse after bone marrow transplantation) in 1989 (DSMZ catalog number AAC 2200
EFO_0006608	KCI-MOH1	human pancreatic adenocarcinoma cell line from the moderately differentiated adenocarcinoma of the head of the pancreas from a 74-year-old African-American man in 1996 (DSMZ catalog number ACC 498)
EFO_0006609	KHM-1B	human multiple myeloma cell line established from a pleural effusion of a 53 year old man with IgA lambda multiple myeloma with hyperamylasemia
EFO_0006610	KLM-1	human pancreatic carcinoma cell line
EFO_0006611	KMM-1	human multiple myeloma cell line from a 62 year old Japanese male
EFO_0006612	KMS-12-BM	human multiple myeloma cell line established from the bone marrow of a 64-year-old woman with multiple myeloma in 1988 (DSMZ catalog number ACC 551)
EFO_0006613	KMS-12-PE	human multiple myeloma cell line established from the bone marrow of a 64-year-old woman with multiple myeloma in 1988
EFO_0006614	KMS-21-BM	human multiple myeloma cell line from a 62 year old Japanese male
EFO_0006615	KMS-26	human multiple myeloma cell line from a 50 year old Japanese male
EFO_0006616	KMS-27	human multiple myeloma cell line from a 52 year old Japanese male
EFO_0006617	KMS-28BM	human multiple myeloma cell line from a 77 year old female
EFO_0006618	KMS-28PE	human multiple myeloma cell line from a 77 year old Japanese female
EFO_0006619	KMS-34	human multiple myeloma cell line from a 60 year old Japanese female
EFO_0006620	KNS-62	human non-small cell lung carcinoma line established from a 49 year old male patient with a non-small cell lung carcinoma
EFO_0006621	KP-2	human pancreatic carcinoma cell line established from a 50 year old Japanese male with pancreatic ductal cell carcinoma
EFO_0006622	KP-3	human pancreatic adenosquamous carcinoma cell line from a 75 year old Japanese male
EFO_0006623	KP-4	human pancreatic ductal carcinoma cell line from a 50 year old Japanese male
EFO_0006624	KPL-4	human breast ductal adenocarcinoma cell line from a 52 year old Japanese female
EFO_0006625	KURAMOCHI	human ovarian carcinoma from a Japanese female with ovarian cancer, undifferentiated carcinoma
EFO_0006626	KYSE-140	human esophageal squamous carcinoma cell line derived from the moderately differentiated invasive esophageal squamous cell carcinoma resected from middle intra-thoracic esophagus of a 54-year-old Japanese man prior to treatment (DSMZ catalog number ACC 348)
EFO_0006627	KYSE-150	human esophageal squamous carcinoma cell line established from the poorly differentiated esophageal squamous cell carcinoma resected from upper (cervical) esophagus of a 49-year-old Japanese woman after receiving radiotherapy (DSMZ catalog number ACC 375)
EFO_0006628	KYSE-180	human esophageal squamous carcinoma cell line established from the well differentiated esophageal squamous cell carcinoma resected from middle intra-thoracic esophagus of a 53-year-old Japanese man prior to treatment (DSMZ catalog number ACC 379)
EFO_0006629	KYSE-270	human esophageal squamous carcinoma cell line derived from well differentiated invasive esophageal squamous cell carcinoma resected from middle intra-thoracic esophagus of a 79-year-old Japanese man prior to treatment (DSMZ catalog number ACC 380)
EFO_0006630	KYSE-450	human esophageal squamous carcinoma cell line established from the well differentiated invasive eosphageal squamous cell carcinoma resected from middle intra-thoracic esophagus of a 59-year-old Japanese man prior to treatment (DSMZ catalog number ACC 387)
EFO_0006631	KYSE-510	human esophageal squamous carcinoma cell line established from the well-differentiated eosphageal squamous cell carcinoma with moderate invasion of the adventitia resected from cervical esophagus of a 67-year-old Japanese woman after cisplatin and radiotherapy (DSMZ catalog number ACC 374)
EFO_0006632	KYSE-520	human esophageal squamous carcinoma cell line established from the moderately differentiated invasive eosphageal squamous cell carcinoma resected from lower intra-thoracic esophagus of a 58-year-old Japanese woman prior to treatment (DSMZ catalog number ACC 371)
EFO_0006633	KYSE-70	human esophageal squamous carcinoma cell line established from the poorly differentiated invasive esophageal squamous cell carcinoma resected from middle intra-thoracic esophagus of a 77-year-old Japanese man prior to treatment (DSMZ catalog number ACC 363)
EFO_0006634	LCLC-103H	human large cell lung carcinoma cell line established from the pleural effusion of a 61-year-old Caucasian man with large cell lung carcinoma with giant cells who had received chemo- and radiotherapy (DSMZ catalog number ACC 384)
EFO_0006635	LCLC-97TM1	human large cell lung carcinoma cell line that represents the xenotransplant of a primary tumor which was obtained from a 44-year-old Caucasian man with large cell lung carcinoma who did not have any prior therapy (DSMZ catalog number ACC 388)
EFO_0006636	LN-18	human brain glioblastoma cell line from a 65 year old male of white ethnicity (ATCC CRL-2610)
EFO_0006637	LN-229	human brain glioblastoma cell line from a 60 year old female of white ethnicity (ATCC CRL-2611)
EFO_0006638	LOU-NH91	human lung squamous carcinoma cell line established from the lower right lung lobe removed two months after diagnosis of highly differentiated squamous cell lung carcinoma with metastasis to one lymph node (no visceral involvement) in a 64-year-old woman (DSMZ catalog number ACC 393)
EFO_0006639	LoVo	human colorectal adenocarcinoma cell line established from the metastatic nodule resected from a 56-year-old Caucasian man with colon adenocarcinoma in 1972 (DSMZ catalog number ACC 350)
EFO_0006640	LS 180	human colorectal adenocarcinoma cell line from a 58 year old Caucasian female (ATCC CL-187)
EFO_0006641	LXF-289	human lung adenocarcinoma established from the lung adenocarcinoma of a 63 year old male (DSMZ catalog number ACC 265)
EFO_0006642	LXFL529	human non-small cell lung carcinoma cell line
EFO_0006643	MCF10DCIS.COM	clonal breast cancer cell line derived from a xenograft originating from premalignant MCF10AT cells
EFO_0006644	MDST8	human colon carcinoma cell line establlished from human colorectal tumor explants (Sigma catalog number 99011801)
EFO_0006645	ME-1	human acute myeloid leukemia cell line established from the peripheral blood of a 40-year-old Japanese man with acute myeloid leukemia (AML) FAB M4eo at second relapse in 1988 (DSMZ catalog number ACC 357)
EFO_0006646	ME-180	human epidermoid carcinoma cell line from a 66 year old Caucasian female (ATCC HTB-33)
EFO_0006647	MEL-HO	human skin melanoma cell line established from the primary tumor of a woman with melanoma in 1976 (DSMZ catalog number ACC 62)
EFO_0006648	MeWo	human skin melanoma cell line from a 78 year old Caucasian male
EFO_0006649	MFM-223	human mammary carcinoma cell line obtained from the pleural effusion of a postmenopausal breast cancer patient (Sigma catalog number 98050130)
EFO_0006650	MHH-ES-1	human Ewings' sarcoma cell line established from the ascites of a 12-year-old Turkish boy with Ewing's sarcoma of the left pelvis (with peritoneal metastasis) (DSMZ catalog number ACC 167)
EFO_0006651	MHH-NB-11	human brain neuroblastoma cell line established from a neuroblastoma metastasis at an adrenal site of a 4-year-old white boy in 1986 (DSMZ catalog number ACC 157)
EFO_0006652	MOLM-16	human acute myeloid leukemia cell line established in 1999 from the peripheral blood of a 77-year-old Japanese woman at relapse of acute myeloid leukemia (DSMZ catalog number ACC 555)
EFO_0006653	MOLP-2	human multiple myeloma cell line established from the peripheral blood of a 55-year-old man with IgD lambda type multiple myeloma in 1991 (DSMZ catalog number ACC 607)
EFO_0006654	MOLP-8	human multiple myeloma cell line established from the peripheral blood of a 52-year-old Japanese man with multiple myeloma (stage IIIA, type IgD lambda) in 2002 (DSMZ catalog number ACC 569)
EFO_0006655	MOR	human lung adenocarcinoma cell line (Sigma catalog number 84112312)
EFO_0006657	NCI-H1373	human lung adenocarcinoma cell line from a 56 year old African male
EFO_0006658	NCI-H1435	human non-small cell lung carcinoma cell line from a 35 year old female (ATCC CRL-5870)
EFO_0006659	NCI-H146	human small cell lung carcinoma cell line established from a 59 year old Caucasian male (ATCC HTB-173)
EFO_0006660	NCI-H1568	human non-small cell lung carcinoma cell line from a 48 year old Caucasian female (ATCC CRL-5876)
EFO_0006661	NCI-H1693	human non-small cell lung carcinoma cell line from a 55 year old Caucasian female (ATCC CRL-5887)
EFO_0006662	NCI-H1734	human non-small cell lung carcinoma cell line from a 56 year old female (ATCC CRL-5891)
EFO_0006663	NCI-H1781	human lung adenocarcinoma cell line from a 66 year old Caucasian female (ATCC CRL-5894)
EFO_0006664	NCI-H1869	human non-small cell lung carcinoma cell line from a 58 year old Caucasian male ATCC CRL-5900)
EFO_0006665	NCI-H1882	human small cell lung carcinoma cell line from a 59 year old Caucasian male (ATCC CRL-5903)
EFO_0006666	NCI-H1915	human non-small cell lung carcinoma cell line from a 61 year old Caucasian female (ATCC CRL-5904)
EFO_0006667	NCI-H1944	human non-small cell lung carcinoma cell line from a 62 year old Caucasian female (ATCC CRL-5907)
EFO_0006668	NCI-H196	human small cell lung carcinoma cell line from a 68 year old Caucasian male (ATCC CRL-5823)
EFO_0006669	NCI-H2023	human non-small cell lung carcinoma cell line from a 26 year old Caucasian male (ATCC CRL-5912)
EFO_0006670	NCI-H2073	human lung adenocarcinoma cell line from a 47 year old Caucasian female (ATCC CRL-5918)
EFO_0006671	NCI-H209	human small cell lung carcinoma cell line from a Caucasian male (ATCC HTB-172)
EFO_0006672	NCI-H2106	human non-small cell lung carcinoma cell line from a 58 year old Caucasian male (ATCC CRL-5923)
EFO_0006673	NCI-H2110	human non-small cell lung carcinoma cell line (ATCC CRL-5924)
EFO_0006674	NCI-H2135	human non-small cell lung carcinoma cell line (ATCC CRL-5926)
EFO_0006675	NCI-H2172	human non-small cell lung carcinoma cell line established from a female (ATCC CRL-5930)
EFO_0006676	NCI-H2196	human small cell lung carcinoma cell line from a 67 year old Caucasian male (ATCC CRL-5932)
EFO_0006677	NCI-H2198	human small cell lung carcinoma cell line from a 67 year old Caucasian male (ATCC CRL-5933)
EFO_0006678	NCI-H2369	human lung mesothelioma cell line
EFO_0006679	NCI-H2373	human lung mesothelioma cell line
EFO_0006680	NCI-H2452	human lung mesothelioma cell line (ATCC CRL-5946)
EFO_0006681	NCI-H2461	human lung mesothelioma cell line
EFO_0006682	NCI-H2595	human lung mesothelioma cell line
EFO_0006683	NCI-H2596	human lung mesothelioma cell line
EFO_0006684	NCI-H2722	human lung mesothelioma cell line
EFO_0006685	NCI-H2795	human lung mesothelioma cell line
EFO_0006686	NCI-H28	Human lung carcinoma
EFO_0006687	NCI-H2803	human lung mesothelioma cell line
EFO_0006688	NCI-H2804	human lung mesothelioma cell line
EFO_0006689	NCI-H2810	human lung mesothelioma cell line
EFO_0006690	NCI-H292	human pulmonary mucoepidermoid carcinoma cell line derived from a cervical node metastasis of a pulmonary mucoepidermoid carcinoma from a 32 year old female (SIGMA catalog number 91091815)
EFO_0006691	NCI-H322T	human non-small cell lung carcinoma cell line
EFO_0006692	NCI-H345	human small cell lung carcinoma cell line from a 64 year old Caucasian male (ATCC HTB-180)
EFO_0006693	NCI-H510A	human small cell lung carcinoma cell line from a 56 year old Caucasian male (ATCC HTB-184)
EFO_0006694	NCI-H596	human adenosquamous lung carcinoma cell line from a 73 year old Caucasian male (ATCC HTB-178)
EFO_0006695	NCI-H727	human non-small cell lung carcinoma cell line from the lung of a 65 year old Caucasian female with a non-small cell lung carcinoma, prior to treatment (SIGMA catalog number 94060303)
EFO_0006696	NCI-H847	human small cell lung carcinoma cell line from a 63 year old Caucasian male (ATCC CRL-5846)
EFO_0006697	NCI-H889	human small cell lung carcinoma cell line from a 69 year old Caucasian female (ATCC CRL-5817)
EFO_0006698	NCI-H920	human non-small cell lung carcinoma cell line from a 43 year old Caucasian male (ATCC CRL-5850)
EFO_0006699	NOF151	human normal ovarian fibroblast cell line
EFO_0006700	NU-DUL-1	human B-cell non-Hodgkin lymphoma cell line established in 1982 from the cerebrospinal fluid of a 43-year-old Caucasian man with B-cell non-Hodgkin lymphoma (DSMZ catalog number ACC 579)
EFO_0006701	NUGC-2	human stomach adenocarcinoma cell line from a 56 year old female
EFO_0006702	NUGC-3	human stomach adenocarcinoma cell line from a 72 year old male
EFO_0006703	NUGC-4	human stomach adenocarcinoma cell line from a 35 year old female
EFO_0006704	OAW28	human ovarian serous cystadenocarcinoma cell line from an ascites of patient with ovarian cystadenocarcinoma (Sigma catalog number 85101601)
EFO_0006705	OAW42	human ovarian serous cystadenocarcinoma cell line from an ascites of patient with ovarian cystadenocarcinoma (Sigma catalog number 85073102)
EFO_0006706	OCI-AML2	human acute myeloid leukemia cell line established from the peripheral blood of a 65-year-old man with acute myeloid leukemia (AML FAB M4) in 1986 (DSMZ catalog number ACC 99)
EFO_0006707	OCI-AML5	human acute myeloid leukemia cell line established from the peripheral blood of a 77-year-old man with acute myeloid leukemia (AML M4) in relapse in 1990 (DSMZ catalog number ACC 247)
EFO_0006708	OCI-LY10	human B-cell non-Hodgkin lymphoma cell line established from the bone marrow of a 44-year-old man with B-cell non-Hodgkin lymphoma (B-NHL; diffuse large cell), stage 4B at relapse in 1983 (DSMZ catalog number ACC 722)
EFO_0006709	OCI-LY19	human B-cell non-Hodgkin lymphoma cell line established from the bone marrow of a 27-year-old woman with B-cell non-Hodgkin lymphoma (B-NHL) in 1987 (DSMZ catalog number ACC 528)
EFO_0006710	OCI-LY3	human B-cell non-Hodgkin lymphoma cell line established in 1983 from the bone marrow sample of a 52-year-old man with B-cell non-Hodgkin lymphoma (DSMZ catalog number Acc 761)
EFO_0006711	OCI-LY7	human B-cell non-Hodgkin lymphoma cell line established from the peripheral blood sample of a 48-year-old man with B-cell non-Hodgkin lymphoma in 1984 (DSMZ catalog number ACC 688)
EFO_0006712	OCI-M1	human acute myeloid leukemia cell line established from erythroleukemia blasts (AML M6) of a 62-year-old patient following a 7-year chlorambucil treatment for chronic lymphocytic leukemia (DSMZ catalog number ACC 529)
EFO_0006713	OCI-M2	human acute myeloid leukemia cell line established in 1984 from the leukemic cells of a 56-year-old patient with erythroleukemia (DSMZ catalog number ACC 619)
EFO_0006714	OCUM-1	human stomach adenocarcinoma cell line from a 38 year old Japanese adult
EFO_0006715	Okajima	human stomach adenocarcinoma cell line
EFO_0006716	OPM-2	human multiple myeloma cell line established from the peripheral blood of a 56-year-old woman with multiple myeloma (IgG lambda) in leukemic phase (relapse, terminal) in 1982 (DSMZ catalog number ACC 50)
EFO_0006717	OUMS-23	human colon adenocarcinoma cell line established from a male
EFO_0006720	OVCA420	human ovarian carcinoma cell line established from a female
EFO_0006721	OVCA429	human ovarian adenocarcinoma cell line established from a female
EFO_0006722	OVCA432	human ovarian carcinoma cell line established from a female
EFO_0006723	OVCA433	human ovarian carcinoma cell line
EFO_0006724	OVISE	human ovarian carcinoma cell line from a 40 year old Japanese female
EFO_0006725	OVKATE	human ovarian adenocarcinoma cell line from a 40 year old Japanese female
EFO_0006726	OVMANA	human ovarian adenocarcinoma cell line from a 51 year old Japanese female
EFO_0006727	OVSAHO	human ovarian adenocarcinoma cell line from a 56 year old Japanese female
EFO_0006728	OVTOKO	human ovarian adenocarcinoma cell line from a 78 year old Japanese female
EFO_0006729	PA-TU-8902	human pancreatic adenocarcinoma cell line
EFO_0006730	PA-TU-8988S	human pancreatic adenocarcinoma cell line from a 64 year old female
EFO_0006733	PE/CA-PJ15	human oral squamous carcinoma cell line established from tongue tissue of a 45 year old male patient with oral squamous cell carcinoma (Sigma catalog number 96121230)
EFO_0006734	PK-45H	human pancreatic carcinoma cell line
EFO_0006735	PK-45P	human pancreatic carcinoma cell line
EFO_0006736	PK-59	human pancreatic carcinoma cell line
EFO_0006737	PK-8	human pancreatic carcinoma cell line
EFO_0006739	PSN1	human pancreatic adenocarcinoma cell line (Sigma catalog number 94060601)
EFO_0006741	QGP-1	human pancreatic carcinoma cell line of islet cell origin
EFO_0006742	RC-K8	human B-cell lymphoma cell line established from the peritoneal effusion of a patient with lymphoma, described at the time as true histiocytic lymphoma, in 1984 (DSMZ catalog number ACC 561)
EFO_0006743	RERF-GC-1B	human stomach carcinoma cell line from a 41 year old Japanese male
EFO_0006744	RERF-LC-OK	human lung adenocarcinoma cell line
EFO_0006745	RKN	human ovarian leiomyosarcoma from a 45 year old Japanese female
EFO_0006746	RMG-I	human ovarian mesonephroid adenocarcinoma cell line from a 34 year old Japanese female
EFO_0006747	RMUG-S	human ovarian adenocarcinoma cell line from a 62 year old Japanese female
EFO_0006748	RTS3b	spontaneously immortalised human epidermal keratinocytes
EFO_0006749	SCLC-21H	human small cell lung carcinoma cell line established from the pleural effusion of a 46-year-old Caucasian man with small cell lung carcinoma (DSMZ catalog number ACC 372)
EFO_0006750	SCLC-22H	human small cell lung carcinoma cell line established from the pericardial effusion of a 46-year-old Caucasian man with small cell lung carcinoma (DSMZ catalog number ACC 373)
EFO_0006751	SIG-M5	human acute myeloid leukemia cell line established in 1995 from the bone marrow of a 63-year-old man with acute myeloid leukemia of monocytic origin (DSMZ ACC 468)
EFO_0006752	SK-CO-1	human colorectal adenocarcinoma from a 65 year old Caucasian male (ATCC HTB-39)
EFO_0006753	SKM-1	human myelodysplasic cell line established from the peripheral blood of a 76-year-old Japanese man with acute monoblastic leukemia (AML M5) in 1989 following myelodysplastic syndromes (DSMZ catalog number ACC 547)
EFO_0006754	SNU-216	human stomach carcinoma cell line from a 46 year old female
EFO_0006755	SNU-484	human stomach carcinoma cell line from a 53 year old male
EFO_0006756	SNU-601	human stomach carcinoma cell line from a 34 year old male
EFO_0006757	SNU-620	human stomach carcinoma cell line from a 59 year old female
EFO_0006758	SNU-638	human stomach carcinoma cell line from a 48 year old male
EFO_0006759	SNU-668	human stomach carcinoma cell line from a 68 year old male
EFO_0006760	SNU-719	human stomach carcinoma cell line from a 53 year old male
EFO_0006761	SNU-C1	human colon adenocarcinoma cell line from a 71 year old Asian male (ATCC CRL-5972)
EFO_0006762	SUM229PE	human breast carcinoma cell line established from a female
EFO_0006763	SUP-B15	human acute lymphoblastic leukemia cell line from a 8 year old Caucasian boy (ATCC CRL-1929)
EFO_0006764	TCC-PAN2	human pancreatic carcinoma cell line from a 68 year old Japanese female
EFO_0006765	TK-10	human carcinoma cell line from kidney of a 46 year old male
EFO_0006766	TYK-nu	human ovarian carcinoma cell line
EFO_0006767	TYK-nu.CP-r	human undifferentiated carcinoma cell line
EFO_0006768	U-698-M	human B-cell lymphoma cell line established from the involved tonsil of a 7-year-old boy with lymphoblastic lymphoma at diagnosis prior to therapy in 1972 (DSMZ catalog number ACC 4)
EFO_0006769	UCSD-242l	human skin melanoma cell line
EFO_0006770	UM-UC-1	human bladder transitional carcinoma cell line derived from a bladder cancer metastasis of a black male (Sigma catalog number 06080301)
EFO_0006771	UM-UC-3	human bladder transitional carcinoma cell line from the urinary bladder of a male (ATCC CRL-1749)
EFO_0006773	VMRC-LCD	human lung adenocarcinoma cell line from a male
EFO_0006774	WM-266-4	human skin melanoma cell line from a 58 year old female (ATCC CRL-1676)
EFO_0006775	WSU-DLCL2	human B-cell lymphoma cell line derived from the pleural effusion of a 41-year-old Caucasian man with B-cell non-Hodgkin lymphoma (DSMZ catalog number ACC 575)
EFO_0006776	WSU-FSCCL	human B-cell lymphoma cell line established from the peripheral blood of a 37-year-old white man with low-grade follicular small cleaved cell lymphoma (DSMZ catalog number ACC 612)
EFO_0006777	WSU-NHL	human B-cell lymphoma cell line established from the pleural effusion of a 46-year-old woman with nodular histiocytic lymphoma (refractory, progressive) in 1986 (DSMZ ACC 58)
EFO_0006778	YAPC	human pancreatic carcinoma cell line from a 43 year old Japanese male
EFO_0006779	YMB-1	human breast carcinoma cell line from a 55 year old female
EFO_0006780	YMB-1-E	human breast carcinoma cell line from a 55 year old female
EFO_0006787	HM7	human colon adenocarcinoma cell line
EFO_0007070	ACC112	ACC112 was established from a salivary glad tumor of a 70-year-old male. Adenoid cystic carcinoma cell line supplied by Lurdes Queimado, M.D., Ph.D. Phone: 405-271-4232 (office); 405-271-4279 (lab); cells immortalized by infection with a retrovirus expressing HPV16 E6 and E7
EFO_0007071	BG01	The hES line BG01 with a normal 46XY karyotype was derived from fibroblasts of an embryonic male human.
EFO_0007073	CyT49	This hESC line was isolated using human feeder cells under good manufacturing process (GMP) conditions. NIH registration: 0041.
EFO_0007074	DND-41	DND-41 was established from the peripheral blood of 13-year-old boy with T-acute lymphoblastic leukemia (T-ALL; type III cortical) in 1977; described to carry CDKN2B (p15INK4B) and CDKN2A (p16INK4A) deletions and TP53 (p53)mutation.
EFO_0007076	ES-I3	The I3 stem cell line was derived from donated blastocysts by removal of the trophoblast layer and further culturing of the intact inner cell mass on mitotically inactivated mouse embryonic fibroblast (MEF) feeder cells. Following injection into SCID mice, the I3 line formed teratomas that contained tissues from all three embryonic germ layers. This line exhibits a normal XX karyotype. These cells were provided by Alex Meissner and maintained in mTeSR medium.
EFO_0007078	HUES13	Human embryonic stem cell line with a normal 46XY karyotype, pluripotency tested in vitro and in vivo. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [DOI: 10.1056/NEJMsr040330]. Cells were provided by Harvard University and maintained on 10% KOSR (Invitrogen) medium.
EFO_0007079	HUES28	Human embryonic stem cell line with a normal 46XX karyotype, pluripotency tested in vivo (teratoma). The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [PMCID: PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007080	HUES3	Human embryonic stem cell line with a normal 46XY karyotype, pluripotency tested in vitro and in vivo. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [DOI: 10.1056/NEJMsr040330]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007081	HUES44	Human embryonic stem cell line derived from human blastocysts. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on 10% KOSR (Invitrogen) medium.
EFO_0007082	HUES45	Human embryonic stem cell line derived from human blastocysts. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on 10% KOSR (Invitrogen) medium.
EFO_0007083	HUES48	Human embryonic stem cell line with a normal 46XX karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, NANOG, and TRA-1-81. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007084	HUES49	Human embryonic stem cell line with a normal 46XX karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, and NANOG. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007085	HUES53	Human embryonic stem cell line with a normal 46XY karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, TRA1-60, TRA1-81 and NANOG. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007086	HUES6	Human embryonic stem cell line with a normal 46XX karyotype, pluripotency tested in vitro and in vivo. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [DOI: 10.1056/NEJMsr040330]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007087	HUES62	Human embryonic stem cell line with a normal 46XX karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, and NANOG. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007088	HUES63	Human embryonic stem cell line with a normal 46XY karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, and NANOG. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007089	HUES64	Human embryonic stem cell line with a normal 46XY karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, and NANOG. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007091	HUES65	Human embryonic stem cell line with a normal 46XY karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, and NANOG. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007092	HUES66	Human embryonic stem cell line derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, NANOG, and TRA-1-60. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007093	HUES8	Human embryonic stem cell line with a normal 46XY karyotype, pluripotency tested in vitro and in vivo. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [DOI: 10.1056/NEJMsr040330]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007094	HUES9	Human embryonic stem cell line with an abnormal 46XX, Inv9 karyotype, pluripotency tested in vitro and in vivo. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [DOI: 10.1056/NEJMsr040330]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007095	iPS DF 19.7	IPS DF 19.7 cell line is an induced pluripotent stem cell line, derived from newborn foreskin fibroblasts. Cells were received from the James Thomson laboratory, who originally reprogrammed the cells from fibroblasts provided by ATCC (Cat# CRL-2097TM). The first set of numbers before the period refer to different clones, the number after the period indicates the sub-clone. The differentiation method is described here: http://www.sciencemag.org/cgi/content/full/324/5928/797?rss=1
EFO_0007096	iPS DF 19.11	Human induced pluripotent stem cell line line derived from foreskin fibroblasts, isolated as described by Yu, J. et al. Human induced pluripotent stem cell lines free of vector and transgene sequences. Science 324, 797-801 (2009). Cells were received from the James Thomson laboratory, who originally reprogrammed the cells from fibroblasts provided by ATCC. The first set of numbers before the period refer to different clones, the number after the period indicates the sub-clone. Cells were maintained on mTeSR medium.
EFO_0007097	iPS DF 4.7	IPS DF 4.7 cell line is an induced pluripotent stem cell line, derived from newborn foreskin fibroblasts. Cells were received from the James Thomson laboratory, who originally reprogrammed the cells from fibroblasts provided by ATCC (Cat# CRL-2097TM). The first set of numbers before the period refer to different clones, the number after the period indicates the sub-clone. The differentiation method is described here: http://www.sciencemag.org/cgi/content/full/324/5928/797?rss=1
EFO_0007098	iPS DF 6.9	Human induced pluripotent stem cell line line derived from foreskin fibroblasts, isolated as described by Yu, J. et al. Human induced pluripotent stem cell lines free of vector and transgene sequences. Science 324, 797-801 (2009). Cells were received from the James Thomson laboratory, who originally reprogrammed the cells from fibroblasts provided by ATCC. The first set of numbers before the period refer to different clones, the number after the period indicates the sub-clone. Cells were maintained on mTeSR medium.
EFO_0007099	iPS-11a	Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: normal, 46XY [90%]; abnormal, extra marker chr [10%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4. [PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007100	iPS-11b	Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: normal, 46XY [95%]; abnormal, 47XY +1 [5%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4. [PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007101	iPS-11c	Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: normal, 46XY [75%]; abnormal, 46 XY del in chr 2 [25%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on 10% KOSR medium.
EFO_0007102	iPS-15b	Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XX [55%]; Abnormal, +(1)(q25.3) [40%]; trisomy X, +(1)(q25.3) [5%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007103	iPS-17a	Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XX. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4. [PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007104	iPS-17b	Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XX. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007105	iPS-18a	Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XX [90%]; Abnormal, 45XO [10%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007106	iPS-18b	Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XX. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007107	iPS-18c	Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XX. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007108	iPS-20b	Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XY [90%]; Abnormal, non clonal tetraploid [10%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007109	iPS-27b	Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Abnormal, 47XX +17, addition to 9 [80%]; Normal, 46XX [10%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on 10% KOSR medium.
EFO_0007110	iPS-27e	Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XX [95%]; Abnormal, 47XX +17 [5%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on 10% KOSR medium.
EFO_0007111	iPS-5	This induced pluripotent stem cell (iPSC) line was generated from dermal fibroblasts, by viral transduction of OCT4, SOX2, KLF4, MYC, hTERT, and SV40 large T (hTERT and SV40 large T did not integrate).
EFO_0007112	Loucy	Loucy was established in 1987 from the peripheral blood of a 38-year-old female patient with T-cell acute lymphoblastic leukemia (T-ALL) obtained two months prior to her death. May be of value in evaluating the role of t(16;20) in the etiology of T-ALL.
EFO_0007116	UCSF4	The hESC line UCSF4 with a normal 46XX karyotype was derived from a blastocyst-stage embryo on human foreskin fibroblasts.
EFO_0007599	L1-S8	L1-S8 is a partially reprogrammed cell line generated from human bone marrow mononuclear cells (BMMCs) after prestimulation with early cytokines (TPO, FL, SCF, IL-3) and transduced with Sendai viruses expressing the four factors OCT4, SOX2, KLF4 and cMYC. It originated from a single colony manually picked and clonal expanded.
EFO_0007600	L1-S8R	L1-S8R is a human iPSC line derived from L1-S8 after transduction with lentiviral vector pLM-fSV2A (Papapetrou et al NBT 2011) expressing OCT4, SOX2, KLF4 and cMYC.
EFO_0007610	RWPE2	RWPE-2 cells were derived from RWPE-1 cells (ATCC CRL-11609) by transformation with Ki-ras using the Kirsten murine sarcoma virus (Ki-MuSV).
EFO_0007611	SU-DHL-2	Human anaplastic large cell lymphoma cell line, established from the pleural effusion of a 73-year-old female. Most of these cells were hyperdiploid, with a sharp modal number of 51 chromosomes; occasional cells in the hypertetraploid range were also seen. A minute marker chromosome was consistently observed, and increased numbers of chromosomes were seen in the A, B, C, and F groups
EFO_0007752	VCaP	Human prostate cancer cell line.
EFO_0007950	GM23338	Induced pluripotent stem cell line; Participant #1 (hu43860C) in the Personal Genome Project: http://www.personalgenomes.org Fibroblast culture from this same subject from which this cell line was made is GM23248and a matching lymphoblast line from this same subject is GM20431.
EFO_0007951	hFib2-iPS4	This induced pluripotent stem cell (iPSC) line was generated from dermal fibroblasts, by viral transduction of OCT4, SOX2, KLF4, c-MYC, hTERT, and SV40 Large T antigen transgenes. Cells express pluripotent markers and have a normal karyotype, 46XY.
EFO_0007952	iPS-NIHi11	Induced pluripotent stem cell line isolated from skin sample AG20443.
EFO_0007953	iPS-NIHi7	Induced pluripotent stem cell line isolated from skin sample AG08395.
EFO_0009318	HFFc6	Human foreskin fibroblast cell line immortalized by infection with retroviral constrcuts that expressed the hTERT open reading frame
EFO_0009747	GM25256	Induced pluripotent stem cell line derived from adult skin (leg) fibroblasts; subject clinically normal; wild-type; FISH test: 46, XY.
EFO_0010973	NOZ	A human cancer cell line, derived from ascites of a patient of peritonitis carcinomatosa. The patient was diagnosed with adenocarcinoma tubular ++, moderately differentiated. This cell line was composed of polygonal, spindle and round shaped cells.
EFO_0022342	gist882	Human GIST882 cell line with activating Kit mutation (K643E)
EFO_0022343	SH-EP1 cell	Human neuroblastoma cell line, established from brain bone marrow tissue from a 4 years old caucasian white with neuroblastoma
EFO_0022344	Val cell	Human B-acute lymphoblastic leukemia (B-ALL) cell derived from the bone marrow of a 50-year-old woman with B-ALL; cells were described in the literature to carry the three-way-translocation t(8;14;18) and to overexpress the BCL2 and MYC genes
EFO_0022345	CUTLL1 cell	CUTLL1 is a human T-cell lymphoblastic lymphoma cell line derived from a relapsed patient that harbors a t(7;9)(q34;q34) chromosomal translocation resulting in expression of a TCRB-NOTCH1 fusion transcript and aberrant Notch signaling
EFO_0022346	76N cell	Normal human mammary epithelial cells
EFO_0022347	GM07166VA7 cell	SV40 T-antigen transformed derivative of GM07166 NBS1 fibroblast cells.
EFO_0022348	184A1 cell	immortal continuous human mammary epithelial cells
EFO_0022349	BL-60 cell	Malignant Burkitt lymphoma cell line BL 60
EFO_0022350	T5-1	An Epstein-Barr virus (EBV) transformed lymphoblastoid cell line with Human Leukocyte Antigen (HLA)
EFO_0022351	REN	Pleural epithelioid mesothelioma cell line
EFO_0022352	SCC12F2	Normal human epidermal premalignant keratinocyte-derived cell line
EFO_0022353	KMC-1	cholangiocellular (bile duct) carcinoma cell line
EFO_0022354	HBC4 cell	Human breast cancer cell line HBC4
EFO_0022355	MDA-Panc-28 cell	Human pancreatic adenocarcinoma cell line.
EFO_0022356	MM1-144	Human myeloma cell line MM1-144
EFO_0022357	NZG0906	human glioblastoma primary tumor-derived line cell
EFO_0022358	Fuji cells	Human Synovial Sarcoma cell line expressing SYT-SSX2 fusion protein.
EFO_0022359	SK-LC-5	Human lung adenocarcinoma cell line
EFO_0022360	WT47 cells	An Epstein-Barr virus (EBV) transformed lymphoblastoid cell line with Human Leukocyte Antigen
EFO_0022361	NA8-MEL cells	Human melanoma cell line NA8
EFO_0022362	Me67 cells	Human melanoma cell line ME67
EFO_0022363	SLB-1 cells	Homo sapiens T cell, HTLV-1 immortalized
EFO_0022364	Mel202 cells	Human uveal melanoma cell line Mel202
EFO_0022365	NK3.3 cell	Human Natural killer cell
EFO_0022366	WM852 cell	Human melanoma cell line WM852
EFO_0022367	D04 cell	Human melanoma cell line D04
EFO_0022368	MM415 cell	MM415 human melanoma cell line
EFO_0022369	MM485 cell	MM485 human melanoma cell line
EFO_0022370	WM1791c cell	Human WM1791c melanoma cells
EFO_0022371	PMWK cell	Human PMWK melanoma cells
EFO_0022372	UT7 cell	Human megakaryoblastic cell line
EFO_0022373	GM09607 cell	ATM-/- fibroblast cell line GM09607
EFO_0022389	ECV304 cell	Human umbilical cord, endothelial ECV304
EFO_0022390	GM03318 cell	Human GM03318 fibroblast obtained from patients with Coffin-Lowry Syndrome (CLS).
EFO_0022391	GM02184 cell	Human lymphoblastoid cell line
EFO_0022392	GM05849 cell	Human Ataxia telangiectasia fibroblast cell line SV40 transformed.
EFO_0022393	MT2 cell	Human T cell, lymphoblast, Human T Lymphotrohpic Virus 1 (HTLV-1) immortalized
EFO_0022398	TF1 cell	TF-1 have been derived from a patient with erythroleukaemia. They show complete growth dependency on GM-CSF or IL-3, and carry a homogeneous chromosomal abnormality (54,X).
EFO_0022399	AML-193 cell	Human acute monocytic leukemia cell line, established from a 13 years old gir
EFO_0022400	NT2-N cell	Human neuronal (NT2N) cells derive from an NT2 human teratocarcinoma cell line
EFO_0022401	SK-N-BE(2) cell	The SK-N-BE(2) neuroblastoma cell line was established in November of 1972 from a bone marrow biopsy taken from child with disseminated neuroblastoma after repeated courses of chemotherapy and radiotherapy
EFO_0022402	Saos-2 cell	Homo sapiens SAOS-2 cell line established from primary osteogenic sarcoma
EFO_0022403	WS1 cell	WS1 is a fibroblast cell isolated from the skin of a Black female donor
EFO_0022404	KM-12C cell	Colorectal carcinoma cell line derived from a primary tumor
EFO_0022405	HN-5 Cell	Well-differentiated human squamous carcinoma cell line (LICR-LON-HN5)
EFO_0022406	MNT-1 cell	Human melanoma cell line
EFO_0022407	AG11395 cell	Human Werner Syndrome (WS) cell line transformed with SV40
EFO_0022408	HBL-1 cell	HBL-1 (aka human is an EBV-negative B-cell lymphoma cell line established from the pleural effusion of a patient with malignant lymphoma, diffuse, large cell.
EFO_0022409	REH cell	Human B cell precursor leukemia REH cells
EFO_0022410	hTERT-HME1 cell	hTERT-HME1 non-oncogenic immortalized mammary epithelial cell line
EFO_0022411	BOSC-23 cell	Human embryonic kidney cell line
EFO_0022413	ARP-1 cell	Human myeloma cell line MM1-144
EFO_0022414	ALL-SIL cell	ALL-SIL -Human T-ALL (T cell acute lymphoblastic leukemia) cell line
EFO_0022415	hTERT-HPNE cell	Human normal pancreas duct cell line; established from a 52 years old male
EFO_0022416	L-540 cell	Human Hodgkin lymphoma cell line, established from the bone marrow of a 20-year-old woman with Hodgkin lymphoma (nodular sclerosis; stage IVB, pre-terminal stage).
EFO_0022417	RWP-1	Human pancreatic adenocarcinoma cell line
EFO_0022418	EJ138 cell	Human bladder transitional cell carcinoma cell line
EFO_0022420	PEER cell	Human T cell leukemia; established from the peripheral blood of a 4-year-old girl with T cell acute lymphoblastic leukemia (T-ALL) in second relapse in 1977
EFO_0022421	T1 (174 x CEM.T1) cell	Human lymphoblastoid cell line
EFO_0022422	Eca-109 cell	Human esophageal squamous carcinoma cell line
EFO_0022423	YT cell	Human T/NK cell leukemia cell line, established from the pericardial fluid of a 15-year-old man with acute lymphoblastic leukemia (ALL) at relapse (with accompanying thymoma) in 1983
EFO_0022424	SK-MEL-37 cell	Human cell line established from a metastatic melanoma
EFO_0022425	RHEK-1 cell	The human epidermal keratinocyte line, designated RHEK-1, was used at passage 23 for these transformation studies. This cell line was established from primary foreskin epidermal keratinocytes after infection with the Adl2-SV40 hybrid virus
EFO_0022426	M-07E cell	A subline of the M-07 human megakaryoblastic leukemia cell line
EFO_0022427	TOV-21G cell	Human ovary cancer cell line
EFO_0022428	KOPN-8 cell	Human B cell precursor leukemia cell line (MLL-ENL fusion)
EFO_0022429	MUM-2B cell	Highly invasive human uveal melanoma line
EFO_0022430	RCC-4 cell	Renal cell carcinoma cell line stably transfected with an empty expression vector, pcDNA3, conferring neomycin resistance
EFO_0022431	HOSE cell	Human ovarian surface epithelial cell line.
EFO_0022432	2fTGH cell	The human sarcoma cell line HT 1080 was transfected with a vector encoding the selectable marker guanine phosphoribosyltransferase regulated by alpha interferon to create the 2fTGH cell line, enabling the selection of mutations in genes encoding components of the interferon signalling pathway
EFO_0022433	C8161.9 cell	Human highly metastatic melanoma cell line
EFO_0022434	MEL-JUSO cell	Human melanoma, established from the primary tumor of a 58-year-old woman with melanoma in 1977
EFO_0022435	CL1-0 cell	Human lung adenocarcinoma cell line. The human lung cancer cell line CL1 was established from a 64-years-old man with a poorly differentiated adenocarcinoma
EFO_0022436	CL1-5 cell	Human lung adenocarcinoma cell line
EFO_0022437	LIM1215 cell	Human colonic cancer cell line
EFO_0022438	NCCIT cell	Human pluripotent embryonal carcinoma, teratocarcinoma cell line; established in 1985 from a mediastinal mixed germ cell tumor of an adult Japanese male. This pluripotent stem cell line is capable of somatic and extraembryonic differentiation
EFO_0022439	ML-1 cell	Human acute myeloblastic leukaemia cell line from human peripheral blood
EFO_0022440	KGN cell	A steroidogenic human ovarian granulosa-like tumor cell line, from a patient with invasive ovarian granulosa cell carcinoma
EFO_0022441	TGW cell	Human TGW neuroblastoma cells
EFO_0022442	PC-3M cell	Human prostate cancer cell line.
EFO_0022443	553B-mel	Human metastatic melanoma cell line
EFO_0022444	KP-L-RY	Human infant acute lymphoblastic leukemia cell line
EFO_0022445	LCL2	Human lymphoblastoid cell line 2, in vitro transformed EBV-positive
EFO_0022446	MOLM-14 cell	Human acute myeloid leukemia cell line. Sister cell line of MOLM-13 cell
EFO_0022447	U-343MG cell	Human glioblastoma cell line
EFO_0022448	GripTite 293 MSR cell	The GripTite™ 293 MSR Cell Line is a genetically engineered Human Embryonic Kidney (HEK 293) cell line that expresses the human macrophage scavenger receptor and strongly adheres to standard tissue culture plates for dependable results
EFO_0022449	RCC-10 cell	Human renal clear cell carcinoma cell line. 
EFO_0022450	HB1119 cell	Human acute lymphoblastic leukemia cell line
EFO_0022451	AT3ABR cell	Human ataxia telangiectasia lymphoblastoid cell line
EFO_0022452	Mel-RM cell	Human melanoma cell line
EFO_0022454	3A(tPA-30-1) cell	human placenta-derived cell line
EFO_0022455	BE3	Human esophagus adenocarcinoma cell line
EFO_0022457	VMRC-RCW cell	Human renal carcinoma cell line
EFO_0022458	HPB-ALL cell	Human T cell leukemia cell line; established from the peripheral blood of a 14-year-old Japanese boy with ALL and thymoma at diagnosis in 1973
EFO_0022459	CWR-22 cell	Androgen-dependent human prostate cancer cell line.
EFO_0022461	HEK-293FT cell	The 293FT cell line is a fast-growing, highly transfectable clonal isolate derived from human embryonal kidney cells transformed with the SV40 large T antigen
EFO_0022462	NOMO-1 cell	Human acute myeloid leukemia cell line; established from the bone marrow of a 31-year-old woman with acute myeloid leukemia at 2nd relapse
EFO_0022497	SNG-M	Human endometrial adenocarcinoma cell line
EFO_0022498	HT-H	Human teratocarcinoma cell line
EFO_0022499	M426	SV40T transformed human diploid fibroblast
EFO_0022500	P493-6	Human Burkitt's lymphoma cell line.
EFO_0022502	NB-1	Human neuroblastoma cell line
EFO_0022503	92-1	Human uveal melanoma
EFO_0022504	SW707	Human colorectal adenocarcinoma cell line
EFO_0022505	SYO-1	Human synovial sarcoma cell line
EFO_0022511	CCD-1070Sk	Human foreskin fibroblasts
EFO_0022512	KN73	Human hepatoma cell line
EFO_0022514	A-375P	Human melanoma cell line
EFO_0022515	HEK-293S	Human HEK-293S cell line
EFO_0022516	2C4 gamma2A	Human fibrosarcoma cell line
EFO_0022518	CH7C17	Human acute lymphoblastic leukemia cell line
EFO_0022519	GM847	Human SV40-immortalized skin fibroblast cell line, telomerase-negative
EFO_0022520	CHRF-288	Human acute megakaryoblastic leukemia cell line
EFO_0022521	D54	Human melanoma cell line
EFO_0022522	DKO-1	Human colon adenocarcinoma cell line
EFO_0022523	KBM-3	Human acute myelomonocytic leukemia cell line with FLT3 ITD
EFO_0022524	EUFA1341	SV40-transformed skin fibroblast cell line derived from an FA-N patient with biallelic mutations in PALB2, a nonsense mutation (c.1802T>A, p.Y551*) on one allele and a loss of the other allele due to a genomic deletion, which result in the expression of a truncated PALB2 protein lacking the ability to bind BRCA2 and recruit BRCA2-RAD51 following DNA damage.
EFO_0022525	Hana3A	Human fetal kidney cell line
EFO_0022526	HCC2429	Human lung non-small cell carcinoma cell line
EFO_0022527	HCS-2/8	Human chondrosarcoma cell line
EFO_0022531	HTC75	Human fibrosarcoma cell line
EFO_0022536	SKLU-1	Human non-small cell lung cancer cell line
EFO_0022538	Yamato-SS	Human synovial sarcoma cell line bearing the SS18-SSX1 chromosomal translocation
EFO_0022539	hTERT-RPE1	The hTERT-immortalized retinal pigment epithelial cell line, hTERT RPE-1, was derived by transfecting the RPE-340 cell line with the pGRN145 hTERT-expressing plasmid
EFO_0022540	J.CaM2.5	Human T-cell acute lymphoblastic leukemia cell line
EFO_0022541	JPM50.6	Human Jurkat T-cell leukemia cell line
EFO_0022542	J14	Human Jurkat J14 T-cell leukemia cell line
EFO_0022543	Kit225	Human T-cell prolymphocytic leukemia cell line
EFO_0022544	KK-47	Human urinary bladder transitional cell carcinoma cell line
EFO_0022545	KT-1	Human chronic myelogenous leukemia cell line
EFO_0022549	MRC-5V1	Human lung fibroblast cell line transformed with simian virus 40, MRC-5 cells are their untransformed progenitors
EFO_0022550	NKL	Human Natural killer cell lymphoblastic leukemia/lymphoma cell line
EFO_0022551	HK-1	Human EBV-negative nasopharyngeal carcinoma cell line
EFO_0022552	PAXC002	Human gemcitabine-resistant pancreatic cancer cell line
EFO_0022555	GM00232	Human  spinal muscle atrophy fibroblast cell
EFO_0022556	TIG-3	Human embryonic lung fibroblast cell line.
EFO_0022557	WHCO6	Human esophageal squamous cell carcinoma cell line
EFO_0022558	WM-35	Human melanoma cell line, derived from the primary radial growth phase tumor site.
EFO_0022559	WM278	This cell line was established from skin taken from a patient with primary nodular melanoma in vertical growth phase.
EFO_0022565	KCL-22	A Philadelphia chromosome-positive cell line established from peripheral blood of a patient with chronic myelogenous leukemia in blast crisis
EFO_0022566	SW13/cl.2 vim-	Adrenal cortex carcinoma cell line that does not express vimentin
EFO_0022567	Aska-SS	Human synovial sarcoma cell line bearing the SS18-SSX1 chromosomal translocation
EFO_0022568	HEK-293-Flp-In	Immortal human kidney-derived derived from the 293 cell line
EFO_0022569	48BR	Human primary fibroblast cell line
EFO_0022570	AG02603	Human lung-derived fibroblast cell line
EFO_0022571	ONS-76	Human medulloblastoma cell line
EFO_0022572	MED-MEB-8A	Human medulloblastoma cell line
EFO_0022573	CLB-SAV	Human lobular breast carcinoma cell line
EFO_0022574	Rh-4	Human alveolar rhabdomyosarcoma cell line
EFO_0022575	TYS	Human salivary gland adenosquamous carcinoma cell line
EFO_0022576	EC-9706	Human esophageal carcinoma cell line
EFO_0022577	D-270MG	Human glioblastoma cell line
EFO_0022578	G-292	Human osteosarcoma cell line
EFO_0022580	BL-41	Human Burkitt lymphoma cell line; established from the tumor tissue of an 8-year-old Caucasian boy with Burkitt lymphoma
EFO_0022583	SNU-251	Human ovarian endometrial cancer cell line
EFO_0022584	SACC-LM	Human salivary gland adenoid cystic carcinoma cell line
EFO_0022586	M249	Human melanoma cell line BRAF V600E mutation
EFO_0022587	HKB-11	Human somatic cell hybridoma (fused human embryonic kidney cells (293S) and modified Burkitt's lymphoma cells (2B8))
EFO_0022588	EUFA143	Human Fanconi anemia cell line
EFO_0022589	EUFA121	Human Fanconi anemia cell line
EFO_0022592	CAL-33	Human tongue squamous cell carcinoma established from the surgically removed fragment of a tongue lesion from a 69-year-old man with moderately differentiated squamous cell carcinoma of the tongue in 1983 (prior to therapy).
EFO_0022593	YTS-Eco	Human NK cell lymphoblastic leukemia/lymphoma cell line
EFO_0022594	HCN-1A	Human cortical neuronal cell line, established from a 18 months old female patient that suffered from unilateral megalencephaly.
EFO_0022595	PNT2	Human normal prostate epithelium cell line immortalized with SV40.
EFO_0022616	BD-215	Human Fanconi anemia cell line
EFO_0022617	MM200	Human melanoma cell line
EFO_0022618	MGR3	Human glioblastoma cell line
EFO_0022619	Rh-28	Human alveolar rhabdomyosarcoma cell line
EFO_0022620	CFBE41o-	Human Cystic fibrotic bronchial epithelial cell line
EFO_0022621	OECM-1	Human oral squamous cell carcinoma cell line
EFO_0022622	LCL 721.221	Human lymphoblastoid cell line
EFO_0022623	SOSP-9607	Human osteosarcoma cell line
EFO_0022625	ST-1	Human adult T cell lymphoma cell line
EFO_0022626	C666	Human nasopharyngeal carcinoma cell line
EFO_0022627	U-178MG	Human astrocytoma cell line
EFO_0022629	TPC-1 	Human papillary thyroid carcinoma cell line
EFO_0022630	AC16	Human hybrid cardiomyocyte
EFO_0022632	2BS	Human transformed human fetal lung cell line
EFO_0022633	IHCF	Human immortalized corneal fibroblast
EFO_0022634	H157	Human oral squamous cell carcinoma cell line
EFO_0022635	PRIESS	EBV-transformed human lymphoblastoid cell line
EFO_0022636	FET	Human colorectal cancer cell line
EFO_0022637	T47D:A18	Human invasive breast carcinoma
EFO_0022638	SK-UT-2 	Human endometrial carcinoma cell line
EFO_0022639	MO3.13	Human hybrid cell line that express phenotypic characteristics of primary oligodendrocytes
EFO_0022640	SAVC	Human B-lymphoblastoid cell line
EFO_0022641	BM9	Human B-lymphoblastoid cell line
EFO_0022642	PLH	Human B-lymphoblastoid cell line
EFO_0022643	BON-1 	Human pancreatic neuroendocrine tumor cell line
EFO_0022644	PH5CH8	Human hepatocyte cell line
EFO_0022645	CWR-R1	Human prostate carcinoma cell line
EFO_0022646	HER911	Human embryonic retinoblasts
EFO_0022647	C-28/I2	Immortalized human chondrocyte cell line
EFO_0022648	253J-BV	Highly metastatic variant from human transitional cell carcinoma
EFO_0022649	KHYG-1	Human natural killer cell leukemia
EFO_0022650	UPCI-SCC-131	Human oral squamous cell carcinoma cell line
EFO_0022651	IHKE-1	Human immortalized kidney epithelial cell line
EFO_0022652	C3ABR	Human lymphoblastoid cell line
EFO_0022653	Hs-578Bst 	Human breast epithelial cell line
EFO_0022654	MLS 2645-94	Human myxoid liposarcoma cell line
EFO_0022655	MLS 402-91	Human myxoid liposarcoma cell line
EFO_0022657	HOM-2	Human B-lymphoblastoid cell line
EFO_0022658	TE-1	Human esophageal squamous cell carcinoma cell line
EFO_0022659	EoL-1	Human eosinophilic leukaemia cell line
EFO_0022660	PITOUT	Human lymphoblastoid cell line
EFO_0022661	LCL1	Human lymphoblastoid cell line
EFO_0022662	OSU-2	Human fibroblast cell line
EFO_0022663	HuH-7-Lunet	Human hepatocellular carcinoma cell line
EFO_0022664	Colo-320	Human colorectal cancer cell line
EFO_0022665	SF-188	Human glioma cell line
EFO_0022667	RCB2099	immortal human esophagus-derived cell line
EFO_0022668	OVCAR-10	Human ovarian carcinoma cell line
EFO_0022669	8505C	Human cell line derived from thyroid cancer. Poorly differentiated papillary adenocarcinoma
EFO_0022670	UWR1	Human anaplastic astrocytoma cell line
EFO_0022671	UWR2	Human glioblastoma cell line
EFO_0022672	GES-1	Human normal gastric epithelial cell line
EFO_0022673	BHP5-16	Human amelanotic melanoma cell line
EFO_0022674	K1	Human thyroid gland papillary carcinoma cell line
EFO_0022675	NCI-H3122	immortal human lung-derived cell line
EFO_0022676	SW-1736	Human anaplastic thyroid cancer cell line
EFO_0022677	5-8F	High tumorigenic and metastatic subline of SUNE-1 cell line
EFO_0022678	HCCLM-3	Human hepatocellular carcinoma cell line
EFO_0022679	SACC-83	Human salivary gland adenoid cystic carcinoma
EFO_0022680	T2	Human-human somatic cell hybrid cell line, established by PEG-mediated fusion of the B-lymphoblastoid cell line LCL 721.174 with an 8-azaguanine and ouabain-resistant variant of the T-LCL CEM. Subclone of the T1 cell line which has lost both CEM(R)-derived copies of chromosome 6
EFO_0022681	SO-Rb50	Human retinoblastoma cell line
EFO_0022682	Flp-In-T-REx	T-REx cell derivative with targeted integration of a Flp-In expression vector
EFO_0022683	T-REx-HeLa	Human papillomavirus-related cervical adenocarcinoma
EFO_0022684	T/C-28a2	Human chondrocyte cell line
EFO_0022685	PER.C6	transformed human retinoblast cell line
EFO_0022686	HEK293S GnTI-	N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line
EFO_0022687	HuTu-80	Human duodenal adenocarcinoma cell line
EFO_0022688	LAN-5	Human neuroblastoma cell line
EFO_0022689	FU-OV-1	Human ovarian serous adenocarcinoma cell line
EFO_0022690	697	Human acute lymphoblastic leukemia cell line
EFO_0022691	BPH-1	Human benign prostate hyperplasia; prostate epithelial cells from a 68-year-old man with benign prostate hyperplasia; cells were immortalized with SV-40 large T-antigen; cells were described to express cytokeratins 8, 18, and 19 (but not 14) and to metabolize prostatic androgens
EFO_0022692	IMR-5	Human neuroblastoma cell line
EFO_0022693	HET-1A	Human esophageal cell line; derived in 1986 from human esophageal autopsy tissue by transfection with plasmid pRSV-T consisting of the RSV-LTR promoter and the sequence encoding the simian virus 40 large T-antigen
EFO_0022694	MOLM-13	Human acute myeloid leukemia cell line; established from the peripheral blood of a 20-year-old man with acute myeloid leukemia AML FAB M5a at relapse in 1995 after initial myelodysplastic syndromes
EFO_0022695	U6A	The 2fTGH-U6A Cell Line is part of a panel of IFNy pathway mutant fibrosarcoma cell lines isolated by chemical mutagenesis of IFNy insensitive reporter cells derived from HT1080 cells.
EFO_0022696	HVTs-SM1	Immortalized human vascular smooth muscle cells
EFO_0022697	tsA-201	A transformed human kidney 293 cell line stably expressing an SV40 temperature-sensitive T antigen
EFO_0022698	XPCS2BA	XPCS2BA; also has features of Cockayne syndrome; no evidence of malignancy; bilateral sensorineural hearing loss; dry skin; numerous freckles; hyperpigmented macules; broad-based choreoathetotic gait; brother of GM13025; donor subject is homozygous for a T>C transversion in the ERCC3 gene which results in a phenylalanine-99-to-serine missense mutation [PHE99SER (F99S)].
EFO_0022699	RAO-3	RAO-3 was established by transduction of the Q61L mutant RAS into human mammary epithelial cells that were immortalized with catalytic subunit of telomerase (hTERT)
EFO_0022700	EW-7	Human Ewing Sarcoma cell line
EFO_0022701	MCF-7/C4-12	Human invasive breast carcinoma
EFO_0022702	OV-2008	Human cystadenocarcinoma cell line
EFO_0022703	HSC-3	Human oral squamous cell carcinoma cell line
EFO_0022704	NCM-460	Nonmalignant human colonic epithelial cell line
EFO_0022705	U3118MG	Human glioblastoma cell line
EFO_0022706	U3082MG	Human glioblastoma cell line
EFO_0022707	HKE-3	Clonal derivative from HCT116 colorectal carcinoma cell line, that lacks the mutant k-ras allele
EFO_0022710	Mahlavu	Human hepatocellular carcinoma cell line
EFO_0022711	LX-2	Immortalized human hepatic stellate cell line
EFO_0022712	LN-428	Human glioblastoma cell line
EFO_0022713	Nthy-ori 3-1	Human thyroid follicular epithelial cell line
EFO_0022714	LN-308	Human glioblastoma cell line
EFO_0022715	SK-CO15	Human intestinal epithelial cell line
EFO_0022717	8305C	Human thyroid carcinoma cell line, established from the primary tumor of a 67-year-old woman with primary thyroid undifferentiated carcinoma
EFO_0022718	TCam-2	Human testicular seminoma cell line
EFO_0022719	RH-41	Human rhabdomyosarcoma cell line
EFO_0022720	MEL-JUSO	Human melanoma cell line
EFO_0030018	BLaER1	BLaER1 cell line is a tamoxifen-inducible subclone of the RCH-ACV B-cell leukemia cell line genetically modified using a retrovirus vector to express C/EBPα fused with the estrogen receptor hormone binding domain (ER) and GFP.